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Introduction 
The word amphiphile was coined by Paul Winsor. It comes from two Greek 
roots: amphi means "double" and philos means "affinity". An amphiphilic 
substance exhibits double affinity, which can be defined from the physico-
chemical point of view as a polar-apolar affinity. Amphiphilic compounds bear an 
ionic (cationic, anionic or zwitterionic) or nonionic polar head group and a 
nonpolar hydrophobic portion. The polar portion exhibits a strong affinity for 
polar solvents, particularly water, and it is often called hydrophilic part or 
hydrophile, while nonpolar is called hydrophobe or liphophile. 
The terms amphiphile and surfactant are often used interchangeably. The 
word surfactant originates from surface-active agent. This points to a key property 
of surfactants: their tendency to segregate to an airiwater interface and 
consequently to lower the surface tension compared to pure water. The 
thermodynamic properties of amphiphiles in solution are controlled by the 
tendency for the hydrophobic region to avoid contact with the water, which has 
been termed the hydrophobic effect. This leads to the association of molecules into 
micelles, which are spherical or elongated structures in which the hydrophobic 
inner core is shielded from water by the surrounding corona formed from the 
hydrophilic ends of the molecules. The ability of surfactants to self-aggregate 
depends on its structure, its concentration, the solubilizing media and the method 
used to preparing the self-assemblies. 
Amphiphiles exhibit other properties than tension lowering and this is why 
they are often labeled according to their main use such as: soap, detergent, wetting 
agent, dispersant, emulsifier, foaming agent, bactericide, corrosion inhibitor, 
antistatic agent, etc., or by the structure they are able to build, i.e., membranes, 
microemulsions, vesicles, liposomes, etc. 
Classification of Surfactants 
Surfactants are typically classified on the basis of physical properties or 
functionality and the most important physical property used for classification is 
ionicity, i.e., surfactant is charged or uncharged. The charged surfactants are 
further classified on the basis of nature of charge on the head group of hydrophilic 
moiety. 
Cationic surfactants 
Cationic surfactants yield a positively charged surfactant ion and a 
negatively charged counterion upon dissolution in water. Examples include 
quaternary ammonium salts and amine oxides. Here the surface active head group 
portion bears a positive charge. The prime use of cationic surfactants is their 
tendency to adsorb at negatively charged surfaces, e.g., anticorrosive agents for 
steel, flotation collectors for mineral ores, dispersants for inorganic pigments, 
antistatic agents and fabric softeners, hair conditioners, anticaking agent for 
fertilizers and as bactericides. 
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Examples: 
Cetyltrimethylammoniutn bromide 	 CH3(CH2)i5N'(CII;),,Br 
Dodecylpyridinium chloride 
	 CNC12HzsCl 
Anionic surfactants 
These surfactants give rise to a negatively charged surfactant ion and a 
positively charged counterion (which is, in general, an alkaline metal Na`, KC or 
quaternary ammonium) upon dissolution in water. They are the most commonly 
used surfactants in industrial applications [1, 2] due to their relatively low cost of 
manufacture and they are used in practically every type of detergent. For optimum 
detergency the hydrophobic chain is a linear alkyl group with a chain length in the 
region of 12-16 carbon atoms. 
Examples: 
Sodium dodecyl sulphate 	 CH3(CH2)IIOSO3 - Na' 
Potassium laurate 	 CH3(CH2),000O-K+ 
Zwitterionic surfactants 
Amphoteric or zwitterionic surfactants can behave as anionic, nonionic, or 
cationic species, depending on the pH of the solution. In acidic pH solutions, the 
molecule acquires a positive charge and behaves like a cationic surfactant, where 
in alkaline pH solutions they become negatively charged and behave like anionic 
one. Near the so-called isoclectric point, these surfactants display both charges and 
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are truly amphoteric, often with a minimum of interfacial activity and concomitant 
maximum of water solubility. The change in the charge with pH of zwitterionic 
surfactants affects their properties such as wetting, detergency, foaming, etc. 
Zwitterionic surfactants, particularly the amino acid ones, are quite biocompatible 
and are used in pharmaceuticals and cosmetics. 
Examples: 
Betaines 
R-N-CH,CO0~ 
Imidazolines 	O 
 H2CH2OH 
R 	NHCH 2CH 2NH 
\CH2COO 
Nonionic surfactants 
As their name implies, nonionic surfactants contain only electrically neutral 
head groups. The most common nonionic surfactants are those based on ethylene 
oxide, which are referred as ethoxylated surfactants [3-5]. These surfactants 
include several classes such as alcohol ethoxylates, alkyl phenyl ethoxylates, fatty 
acid ethoxylates, monoalkanol amide ethoxylates, sorbitan ester ethoxylates, etc. 
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Another important class of nonionics is multi-hydroxy products such as 
glycolesters/glycerol (and polyglycerol) esters, glucosides (and polyglucosides) 
and sucrose esters. 
Examples: 
Alkyl phenol ethnxylate 	 Cl-I3 (CH2)1 C5H4-(CF12C H2O)OH 
Poly(ethyleneglycol)-i-octylphenylether [t-C,H1-~-C6H4-(OCH2CH2)nOHJ 
Gemini surfactants 
Gemini surfactants are surfactants consisting of two hydrophilic and two 
hydrophobic moieties linked by a spacer at level of or closed to the head [61 (Fig. 
1.1). Menger and Littau [6] assigned the name of gemini to bis-surfactants with 
rigid spacer (i.e., benzene, stilbene). The name was then extended to other bis or 
double-tailed surfactants, irrespective of the nature of spacers. Geminis were 
known long before to Bunton et at [7], who was the first to synthesise gemini 
surfactants of the bis (quaternary ammonium bromide) type with two C6 chains, 
separated by a spacer having lengths of two, four, or six carbon atoms. Devinsky 
[8] also synthesized his (quaternary ammonium) geminis with chain lengths from 
6 to 18 carbon atoms and spacer of five carbon atoms long, and reported the 
micelle formation of these surfactants. The surface properties of geminis were first 
described by the late Mitsui Okahara of Osaka University and his colleagues [9- 
13], who synthesized them in their laboratories. A considerable number of 
investigations have reported on their unusual physicochemical properties, 
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including their high surface activity [6,13,t4], unusual viscosity changes with an 
increase in surfactant concentration [15], unusual micelle structure [16, 17], 
aberrant aggregation behavior [18], and stronger interaction with oppositely 
charged surfactants [19]. The greater efficiency and effectiveness of geminis over 
comparable conventional surfactants make them cost-effective as well as 
environmentally desirable. The interest of geminis in academic circles and among 
scientists at surfactant-producing companies is due to the following reasons: 
(i) Their erne, on a weight percent basis, is at least one order of magnitude lower 
than for the corresponding single tail — single ncad surfactants. 
(ii) They are 10-100 times more efficient at reducing the surface tension of water 
and the interfacial tension at an oiliwater interface than conventional surfactants. 
(iii) They appear to have better solubilizing, wetting, foaming, and lime-soap 
dispersing ability than the conventional surfactants. Some cationic gemini 
surfactants possess interesting biological properties. 
(iv) The aqueous solutions of some gemini surfactants with a short spacer show 
special theological properties (viscoelasticity, shear-thickening) at relatively low 
concentrations. 
(v) Gemini surfactants can be synthesized with an enormous variety of structures. 
In principle, it is possible to connect any two identical or different surfactants 
among the available ones by a spacer group that can he hydrophilic or 
hydrophobic, flexible or rigid, heteroatomic, aromatic, etc. Therefore, the 
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structures and properties of gemini surfactants can be more finely tuned for a 
given application than for conventional surfactants. 
Tail 	Head 	Spacer 	Head 	Tail 
Fig. 1.1: Stnteture ofgemini swfactant. 
Bolaform surfactants 
Bolaform surfactants consist of two hydrophilic head groups, connected by 
a long hydrocarbon spacer (Fig. 1.2). Their tendency to aggregation is lower, and 
aggregation numbers are smaller than those of the monomeric surfactants of which 
they consist. 
Long polymethytene chain 
F~FTgaA 	 Hc.ul`. 
Fig. 1.2: Schematic representation of a bolaform surfactant. 
Micelle Formation and Critical Micelle Concentration 
Since the beginning of the study of surfactant solutions, it was recognized 
that the physical properties of these solutions, such as surface tension, electrical 
conductivity and detergency, show an abrupt change in the neighborhood of a 
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critical concentration: these unusual properties indicated the formation of 
molecular aggregates. The formation of colloidal sized clusters of individual 
surfactant molecules in solution is now better known as micellization. The word 
micelle is a Latin term meaning "small bit" and was coined by J. W. McBain [20] 
in 1920 to describe colloidal sized particles of detergents and soaps. Micelle 
formation is primarily controlled by three forces: the hydrophobic repulsion 
between the hydrocarbon chains and the aqueous solution, the charge repulsion of 
ionic head groups and the van der Waals attraction between the hydrocarbon tails 
[21, 22]. 
The micellization is of primarily an entropy-driven process. When 
surfactants are dissolved in water, the hydrophobic group disrupts the structure of 
water and therefore increases the free energy of the system. Surfactant molecules 
therefore concentrate at interface, so that their hydrophobic groups are directed 
away from the water and the free energy of the solution is minimized. The 
distortion of the water structure can also be decreased (and the free energy of the 
solution reduced) by the aggregation of surface active molecules into micelles 
with their hydrophobic groups directed towards the interior of micelles and their 
hydrophilic groups directed towards the water. The micelles first appear in 
solution at and above the enrc [23]. The term epic was established by Davis and 
Bury [24] in 1930, defining it as the threshold concentration at which micelles first 
appear in solution. cme is an important property of the surfactants which reflects 
its micellization ability. The physico-chemical properties of surfactants vary 
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markedly above and below the cmc value [25-28]. Below the cmc value, the 
physico-chemical properties of ionic surfactants 	(e.g., conductivities, 
electromotive force) resemble those of strong electrolytes. Above the cmc value, 
these properties change drastically, indicating a highly cooperative association 
process is taking place. This is illustrated by Preston's [29] classic graph (Fig. 1.3). 
Clear breaks of almost every measurable physical property that depends on 
size and number of particles in solution are shown by all types of surfactants, i.e., 
nonionic, anionic, cationic and zwitterionic in aqueous media. A wide variety of 
techniques involving the measurement of physical properties have been used to 
determine cmc value. 
C A IT_ 
.SSOOIW.0 L^URYL SULFATE 
Fig. 1.3: Preston 's classic graph showing variation in physical properties of 
surfactant solutions below and above the cmc value of sodium dodecyl sulphate. 
Factors Affecting the eme 
Structure of the surfactant 
For ionic amphiphiles, increase in the number of carbon atoms in the 
unbranched hydrocarbon chains leads to a decrease in the cmc. As a general rule 
for ionic surfactants, the emc is halved when the length of the straight hydrocarbon 
chain is increased by one methylene group, while in case of nonionic surfactants, 
the addition of one methylene group causes the emc to decrease approximately 1/3 
its original value [30]. Muller et al. [31-34] reported that substitution of the CF3  
groups from the terminal CH} groups of surfactants hydrocarbon chain roughly 
doubles the cmc and it is also confirmed by Gerry at al. [35] who observed 
corresponding decrease in aggregation number. A phenyl group that is a part of 
hydrophobic group with terminal hydrophilic group is equivalent (in its effect on 
eme) to about three and one-half methylene groups. 
In aqueous media, ionic surfactants have a much higher cmc than nonionic 
surfactants with a corresponding hydrocarbon chain, due to the lack of electrical 
work necessary in forming the micelles. 
For usual type of polyoxyethylenated nonionics, the cmc decreases with 
decrease in number of oxyethylene units in the polyoxyethylene chain, since this 
makes the surfactant more hydrophobic. 
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Presence of various additives in the solution 
(a) Effect of electrolyte 
The presence of electrolyte in aqueous solution causes a change in the eme, 
the effect being more pronounced for anionic and cationic than zwitterionic 
surfactants and more pronounced for zwitterionics than for nonionics. The effect 
of concentration of electrolyte on cmc of ionic surfactants is given by the 
following relation [36] 
logeme - a log c, + b 
	
(1.1) 
where a and b are the constants for a given ionic head at a particular temperature 
and c, is the total counterion concentration in equivalents per liter. The depression 
of the cmc in these cases is due mainly to the decrease in the thickness of the ionic 
atmosphere surrounding the ionic head groups in the presence of the additional 
electrolyte and the consequent decreased electrical repulsion between them in the 
micelle. For sodium luarate and sodium naphthenate, the order of decreasing 
effectiveness of the anion in depressing the cmc is PO4 > B1072- > OH-> CO3' 
>HCO3 >SO42- >NO3 >CC[37I. 
The change in the erne of nonionics and zwitterionics on the addition of 
electrolyte has been attributed [38, 39] mainly to the " salting out " or "salting in " 
of the hydrophobic groups in the aqueous solvent by the electrolyte, rather than to 
the effect of the latter on the hydrophilic groups of the surfactant. Salting in or 
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salting out by an ion depends upon whether the ion is a water structure breaker or 
a water structure maker. 
(b) Effect of organic additives 
Small amounts of organic materials may produce marked changes in the 
cmc in aqueous media. Knowledge of the effects of these materials, on the cmc of 
surfactants is therefore of great importance both for theoretical and practical 
purposes. Organic compounds affect the cmc either by penetrating into the 
miccllar region, or by modifying solvent-micelle or solvent-monomer 
interactions. Non-polar compounds, such as hydrocarbons, that are believed to 
penetrate into the inner portion of the core, decrease the cmc only slightly. 
Addition of longer chain alcohols promotes micelle formation and lowers the cmc. 
The magnitude of cmc decrease depends on the alkyl chain length of the organic 
additive and the hydrophilic group associated with the chain. Urea, fonnamide, 
and guanidinium salts are believed to increase the cmc of surfactants in aqueous 
solution because of their disruption of the water structure. These water structure 
breakers may also increase the erne by increasing the entropy effect 
accompanying micellization. 
Temperature 
The influence of temperature on micellization is usually weak, reflecting 
subtle changes in bonding, heat capacity and volume that accompany the 
transition. In general, for ionic surfactants, the erne first decreases in the lower 
12 
range of temperature; at higher temperature it increases [40]. For nonionic 
surfactants, the cmc decreases with increasing temperature [41]. The decrease in 
cmc of ionic surfactants with temperature increase at lower temperatures is 
possibly due to dehydration of the monomers, whilst further temperature increase 
causes disruption of the structured water around the hydrophobic groups which 
opposes aggregation. Also, thermal agitation of molecules at higher temperatures 
results in a decreased self-adhesion between molecules. 
pH 
In amphiphiles containing ionizable group such as —NH,, — (CH3)2 N— 0 
and — COOH, the degree of dissociation will be dependent on pH [42]. In general, 
the cmc will be high at pH values where the group is charged (low pH for —NH2 
and — (CH1)2 N—* 0 and high pH for —COOH) and low when uncharged. Some 
zwitterionic surfactants become cationic at low pH, a change that can be 
accompanied by a rapid rise in the cmc [43] or more modest rise [44] depending 
on structure and hence hydrophilicity of the zwitterionic form. 
Pressure 
It has been suggested that the amphiphile molecules when present in the 
micelle are in a more expanded condition than when present as the monomer in 
solution, so that the initial effect of pressure tend to compress the micelle and 
militate against the increased freedom of the monomer in the micelle, thus giving a 
rise in cmc. The decrease in cmc may be due to an increase in dielectric constant 
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of water, making less electrical work necessary to bring a monomer into micelle. 
Many reports have appeared on the effect of pressure on micelle formation of 
ionic [45-50] and non-ionic amphiphiles [51]. An increase in one occurred with 
increase in pressure approximately upto 105 Mpa, followed by cmc decrease at 
higher pressure. For nonionic amphiphiles, the cmc value increases monotonously 
and then levels off with increasing pressure. La Mesa has also discussed the effect 
of pressure on the cme [52]. 
Solvent medium 
The polarity of the medium favors surfactant association. Nonpolar 
medium offers environment similar to the surfactant tail so that their tendency of 
self-association is reduced. In a good nonpolar medium, viz., cyclohexane, carbon 
tetrachloride, etc., formation of normal micelle may be totally absent; a reverse 
orientation (reverse micelle) may occur. In ethylene glycol, the cmc of surfactants 
decreases as the length of the hydrophobic chain increases. But the change is much 
smaller than in water [53]. For polyoxyethylenated nonionic solutions in benzene 
and carbon tetrachloride. cmc decreases with increase in the length of the 
polvoxyethylene group  at constant hydrophobic chain length. 
The cmc in benzene for alkylammonium carborxylates increases with 
increase in the length of alkyl chain of the anion but decrease with increase in the 
length of the alkyl chain of cation; in carbon tetrachloride, there is no significant 
change in the value of the erne with these structural changes. 
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The one is lower in D20 than H2O for different amphiphilies [54,55]. The 
hydrophobic bonds are expected to be stronger in D_O than H2O [56]. Also, 
micelles in D20 are larger than H2O [57]. 
Tunes of Micelles 
Normal micelle 
In 1920 Mc Bain and Salmon proposed the existence of micelles [20]. It 
was Hartely [58] who made the pioneering contributions to the understanding of 
the micelles. Hartly micelle is described as having linear chains arranged radially, 
as in the spokes of a wheel. The structure of normal micelles just above the one 
can be considered as roughly spherical [59-62]. When the hydrophobic portion of 
the surfactant is a hydrocarbon chain, the micelle will consist of liquid-like 
hydrocarbon core with radius of roughly equal to the fully extended hydrocarbon 
chain length (--12-30 A): the polar head groups with the surrounding water are 
arranged at the micellar surface, which is rough [63]. Menger has proposed that 
water can penetrate inside the micelle upto a certain level [64, 65]; the idea got 
support from fluorescence and 'H-NMR measurements. Partial molar volume 
determinations indicate that the alkyl chains in the core are more expanded than 
those in the normal liquid state [66]. 
An ionic normal micelle may contain three regions (Fig. 1.4). 
(i) The interior or core of the micelle which is hydrocarbon like as it consists of 
hydrocarbon chains of the ionic surfactant molecules. 
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(ii) Surrounding the core is an aqueous layer known as the Stern layer. The Stern 
layer constitutes the inner part of the electrical double layer. It contains the 
regularly spaced charged head groups and 60-90% of the counterions (the bound 
counterions). The head groups are hydrated by a number of water molecules. One 
or more methylene groups attached to the head group may be wet. The core and 
the Stern layer form the kinetic micelle. 
v~ 	
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Fig. 1.4: Schematic representation of the regions of spherical micelle. 
(iii) The outer layer is a diffuse layer and contains the remaining counterions and 
is called the Gouy-Chapman layer that extends further into aqueous phase. The 
thickness of this layer is determined by the (effective) ionic strength of the 
solution. 
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The head groups and counterions concentrations in the interfacial region of 
ionic micelle are on the order of 3-511, which give the micellar surface some of 
the properties of the concentrated salt solution [67]. Although the solution as a 
whole is electrically neutral, both the micellar and aqueous pseudo phase carry a 
net charge because thermal forces distribute a fraction of the counterions radially 
into the aqueous phase [28, 68). 
For nonionic micelles the structure is essentially the same except that the 
outer region contains no counterions, but includes coils of hydrated 
polyoxyethylcne chains, Water molecules appear to be trapped on the oxyethylene 
sites [69]. 
Reverse micelle 
In nonpolar solvents, in the presence of traces of water, surfactants 
associate to form the so-called reverse/inverted micelles. The structure of micelle 
is similar to that of normal micelle but inverted. In a reverse micelle, head group 
of surfactant molecules locate inside to form a polar core and hydrocarbon tails are 
directed towards the bulk solvent to form the outside shell of the micelle [70-73]. 
At a very low concentration of surfactant, the reverse micelles are very close to 
spherical in which water molecules occupy the central part of the sphere, thus 
forming a so-called micro water-pool, and these water molecules are in contact 
with head groups of reverse micelle-forming surfactant molecules. The tails of 
these surfactant molecules are extended toward bulk nonpolar solvent phase (Fig. 
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1.5). The most often used reverse micellar system is the Aerosol OT 
(AOT)iH2O/isooctane system. 
In recent years the field of reverse micelles has witnessed a significant 
growth of interest, partly due to the finding that proteins, other biopolymers, and 
even bacterial cells can be solubilized in the reverse micellar systems: in fact, this 
has permitted the extension of the area of interest to new domains, i.e., 
biocatalysis and chemical biotechnology. 
Fig. 1.5: A two dimensional schematic representation of reverse micelle. 
Mixed micelle 
The formation of micelles from more than one chemical species gives rise 
to what are known as mixed micelles (Fig. 1.6). A mixed micelle is an aggregate 
of surfactant molecules composed of different types of surfactants present in 
aqueous solution. Mixed micellar systems are encountered in many applications, 
E 
from laundry detergents formulation to industrial and technological systems, due 
to their better performance characteristics than those consisting of only one type of 
surfactant [74, 751. 
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M nnom era 	 Mixed .i 11e 
Fig. 1.6: Schematic representation offormation ofmrxed micelle by the 
monomers. 
Mixed micelles are also formed when low molecular weight molecules are 
solubilized by micelles formed from surfactants containing a relatively larger non-
polar side chain. The solubilized substances, also called a penetrating additive 
[76], may be located in the hydrocarbon core [77], or the hydrophilic mantle [78]. 
The mixed micellization is a special case of solubilization. 
The cme of the mixed micelles fall within the highest and lowest 
individual cmc values of components [74]. In some cases, two surfactants interact 
in such a fashion that the erne of the mixture is always intermediate in value 
between those of two pure components. In other cases, they interact in such a way 
that the cmc of the mixture at some ratio of the two surfactants is less than either 
of the cmc. When this situation arises, the system is said to exhibit synergism, the 
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condition in which the properties of the mixture are better than those attainable 
with the individual components by themselves. 
Mixed miceltar solutions exhibit some very interesting properties not 
expected from individual surfactant solutions. When an ionic surfactant is mixed 
with a non-ionic surfactant, the degree of the association falls to zero as mole 
fraction of non-ionic surfactant in the micelle increases [79, 80]. This is 
particularly evident for mixtures of anionic and non-ionic surfactants of the 
polyoxyethylene type, because of the strong interaction between the anionic head 
group and the ethylene oxide group. 
A22reeation Number 
An important property of micelle formation is the mean aggregation 
number which provides direct information about the general size and shape of the 
aggregates formed by atnphiphiles in solutions, and how these properties are 
related to the molecular structure of the amphiphile. The average number of 
monomers making up the micelles is know as aggregation number (N) and is 
typically 30-200 in water. The aggregation number depends on different factors 
such as the nature of surfactants, temperature [81-83], type and concentration of 
added electrolytes [84-86], organic additives [87-89], etc. 
Many experimental techniques like dynamic light scattering (DLS), small 
angle neutron scattering (SANS), steady-state fluorescence quenching (SSFQ), 
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time-resolved fluorescence quenching (TRFG), etc., have been used for 
determination of the aggregation number [90-97]. 
Micellar Packing Parameter 
The morphology of micellar aggregates is mainly determined by a balance 
between hydrophobic interactions of the hydrocarbon tails and the electrostatic 
repulsions and hydration of the head groups [98]. Israelachvili et al. [26] 
developed a model and defined a packing parameter Rp to predict the aggregate 
morphology of a given surfactant 
Rp V11 Ia0 1, 	 (1.2) 
In this equation 1, is the chain length of the fully extended all-trans alkyl tail, VH  
the volume of the hydrophobic part of the molecule, and ao the mean cross-
sectional head group area. V11 and 1, can easily be calculated from the number of 
carbons in the chain through the Tanford equation [98] 
1,=(1.5+ 1.26n)A 	 (1.3) 
and 
V,, = (27.4 + 26.9 n) A3 	 (1.4) 
where it is the number of carbon atoms of hydrophobic chain embedded in the 
micellar core. More tricky is the quantification of a,„ especially for cationic and 
anionic surfactants. The effective size of the head group area depends on the 
electrolyte and the surfactant concentration. Nagarajan [991 proposed that the 
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value of ao possibly also depends on the chain length. The relationships between 
the effective shape and the packing parameter are related as in Table 1.1 
Table 1.1: Aggregate structures with their corresponding packing parameters. 
Effective shape of the Packing parameter Type of aggregation 
surfactant molecule 	(RP) 
<lr3 	 • 
• • 
••i~ 
cone 	 spherical micelles 
truncated cone 	 wormlike micelles 
bilayers 
cylinder 
Vesicles 
>1 
inverted cone 	 reverse micelles 
22 
Thermodynamic Models of Micelle Formation 
The thermodynamics of surfactant systems are of great importance in 
theoretical and practical purposes, as they affect the stability of ordered micelles 
vis-a-vis disordered free surfactant molecules and/or ions in the solution state. The 
thermodynamic analysis of micellization has gained wide acceptance through two 
approaches for application in describing the micelle formation process and thereby 
allow for the relation of macroscopic equilibrium thermodynamic measurements 
to molecular processes. They are the pseudo-phase separation model [100-102], 
which treats micelles as a separate phase formed at and above the cmc, and the 
mass-action model [103-106], which considers surfactant monomers in solution to 
be in equilibrium with micelles of a fixed size above the cmc. An extension of the 
mass-action model is the multiple equilibrium models [107], which consider the 
formation of aggregates of various sizes, accounting for the observed 
polydispersity in aggregation numbers. However, this introduces a large number of 
variables into any analysis of experimental data making it difficult to apply. The 
pseudo-phase separation model has been shown to account for, at least semi-
quantitatively, the observed concentration dependence of apparent molar 
properties and has been useful in deriving thermodynamic functions of 
micellization using both apparent and partial molar properties. The main criticism 
of this model is that calculated values often show substantial deviation from 
experimental values for some properties, particularly if the transition from 
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monomer to micelle formation occurs over a broad concentration range. 
Nevertheless, because of the simplicity of its application, the pseudo-phase model 
is widely used to model thermodynamic data, particularly for long-chain 
surfactants having low cinc values. The mass-action model allows for modeling of 
thermodynamic properties over a broader concentration range, i.e., premicellar 
range as opposed to the pseudo-phase model which is applicable only in the post-
micellar range. Also, prediction of aggregation numbers can be made from the 
mass-action model, and it has been more successfully applied to short chain 
surfactants. In both these treatments, the micellization is described in terms of 
classical system of thermodynamics. 
Pseudo-phase separation model 
This model considers the formation of micelles to constitute the formation 
of a separate phase. However, the micelles do not constitute a "phase" according 
to the true definition of this concept since they are not homogeneous and uniform 
throughout. An underlying argument for this assumption is that the activity of the 
monomer surfactant remains constant above the cinc, as is seen very often in 
surface tension measurements by the near constant value of the surface tension. 
The cinc can, therefore, be considered as the solubility limit of the monomeric 
species. A main criticism to this model is that it predicts that activity of the 
monomers above the cinc remains constant, while dialysis, surface tension and 
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emf measurements indicate a decrease in monomer activity above the cmc of ionic 
surfactants. 
Consider an anionic surfactant, in which n surfactant anions, S-, and n 
counterions M+ associate to form a micelle, i.e., 
nS- + 1tMt =•— — S,, 
The micelle is simply charged aggregate of surfactant ions plus an 
equivalent number of counter ions in the surrounding atmosphere and is treated as 
separate phase. 
The chemical potential of the surfactant in the micellar state is assumed to 
be constant, at any given temperature, and this may be adopted as standard 
chemical potential, um. , by analogy to pure liquid or a pure solid. Considering the 
equilibrium between micelles and monomers, then, 
I', =/''  + RT Ina, 
	 (1.5) 
where ji, is the standard chemical potential of surfactant monomer and a, is its 
activity, which is equal to f x,, where /j is the activity coefficient and x, the mole 
fraction. Therefore, the standard free energy of micellization per mole of monomer 
is given by, 
SG, = /.[' – fit; = RT in a 	RT In x, 	 (1.6) 
where f s is taken as unity ( a reasonable value in very dilute solution). Assuming 
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the concentration of free surfactant in the presence of micelles to be constant and 
equal to the eme value,xCMC , then 
4Gm = RT ln[cmcl 
In equation (1.7), the cmc is expressed as a mole fraction, which is equal to 
(Cl55.5-}C), where C is the concentration of surfactant in M, i.e., 
AG ,°'. =RT InC —RT In(55.5+C) 
,5G,;, should be calculated using cmc expressed as a mole fraction as indicated by 
equation (1.8). 
The phase separation model has been questioned for two main reasons. 
Firstly, according to this model a clear discontinuity in the physical property of a 
surfactant solution, such as surface tension, turbidity, etc., should be observed at 
the tint. This is not always found experimentally and the cmc is not a sharp break 
point. Secondly, if two phases actually exist at the eme, then equating the chemical 
potential of the surfactant molecule in the two phases would imply that the activity 
of the surfactant in the aqueous phase would be constant above the tint. If this was 
the case, the surface tension of a surfactant solution should remain constant above 
the cmc. However, careful measurements have shown that the surface tension of a 
surfactant solution decreases slowly above the eme, particularly when using 
purified surfactants. 
Mass-action model 
This model gives more appropriate description of the micellar process. This 
model predicts micelles and unassociated monomers to be in association-
dissociation equilibrium, i. e., 
Kill 
nS 	 S„ 
K = [S]' 
where Km is the equilibrium constant. 
The standard free energy per monomer is then given by 
_ _ OG ` RT In 
K m  = RT ln[S„ ]— RT In[S] 	 (1.9) 
n 	1r 	 n 
For many micellar systems, n > 50 and, therefore, the first term on the right-hand 
side of equation (1.9) maybe neglected, resulting in equation (I.10) forAG,, 
AGO = RT ln[S] = RT ln[cnic] 
	
(1.10) 
which is identical to equation (1.7) derived using the phase-separation model. 
The mass action model allows a simple extension to be made to the case of 
ionic surfactants, in which micelles attract a substantial proportion of counter ions 
into an attached layer. For a micelle made of n-surfactant ions, where (n p) 
charges are associated with counter ions, i.e., having a net charge of p units and 
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degree of dissociation p/n, the following equilibrium may be established (for an 
anionic surfactant with Na` as counter ions), 
K,,, 
nS + (n p)Nar 	- S„P- 
K= 	lsn1 T 	[S_ ]R[Na+ ],~ ,,, 
Phillips has given a convenient solution for relating AGO to [cmc], arriving at 
equation (1.12) 
AGO = [2 — (R )]RT ln[cmc] 	 (1.12) 
For niany ionic surfactants, the degree of dissociation pin is 0.2, so that, 
JGn = 1.8RT 1n[cmc} 	 (1.13) 
Comparison with equation (1.10) clearly shows that, for similarAG', the [cmc] is 
about two orders of magnitude higher for ionic surfactants than with nonionic 
surfactants of the same alkyl chain length. 
In the presence of excess added electrolyte, with mole fraction x, the free 
energy of micellization is given by the expression, 
AG;n = RT In[cmc] + [1— (L)] In x 	 (1.14) 
Equation (1.14) shows that as x increases, the [cmc] decreases. 
It is clear from equation (1.12) that as p=0, i.e., when most charges are associated 
with counter ions, 
= 2RT ln[cmc] 	 (1.1 5) 
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Whereas, when p—n, i.e., the counter ions are bound to micelles, 
JGm = RT ln[cmc] 	 (1.16) 
which is the same equation as for nonionic surfactants. 
Drugs and their Classification 
The term drug is derived from the French word "Drogue" which means `a 
dry herb'. According to definition of the World Health Organization, a drug is any 
substance or product that is used to modify or explore physiological systems or 
pathological states for the benefit of the recipient [ 108]. In the context of 
medicine, it means a chemical used in the prevention, diagnosis or treatment of 
disease. 
It is to be noted that drugs are to be used for the benefit of recipient and it is 
presumed that this refers to total benefit—physical, mental as well as economical. 
Drugs are regarded as biologically active chemical compounds mostly with a 
therapeutic purpose which can be broadly classified into: 
(i) Biological classification (based on pharmacotherapeutic and chemotherapeutic 
agents) 
(ii) Chemical classification (based on drugs' chemical structure) 
(iii) Classification of drugs according to commercial consideration (classified 
according to operational expenses, research investment, and profit margins) 
(iv) Classification by the lay public (classification depending on the action of the 
drug, like antiseptic, tonics, laxative, etc.). 
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A wide variety of drugs are, in fact, known to be surface active in nature 
[ 109-124]. This activity does not appear to be a fortuitous coincidence. In a 
number of cases excellent correlations between surface activity and biological 
effects have been demonstrated. 
Many pharmacologically active compounds being amphiphilic, may 
undergo different kinds of associations and whose site of action in the organism 
frequently is the plasma membrane. Even if their target is intracellular, the 
interaction with this first barrier plays a fundamental role [ 125]. 
Formation of cell membranes and location of receptor proteins in lipid 
bilayers is a consequence of surface activity. It is, therefore, logical to expect that 
the drugs acting by altering the permeability cell membranes after interacting with 
them are likely to be surface active in nature. This is because the lipid bilayers, 
with receptors in them, represent the interface and the drugs interacting with them 
will not reach the interface unless they are surface active in nature. 
Surface activity is of ubiquitous presence in living systems. Take any body 
fluid or cell soup, its surface tension is always less than that of water. Molecules 
of surface active nature are crucial to living matter and its organization. Formation 
of biological cell is, as a matter of fact, a consequence of surface activity. Surface 
activity in living systems is a matter of evolution, i.e., it is need based and 
therefore should have a crucial role to play in biological action. 
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Theories of Drug Action 
There are three theories relevant to drug action, namely, occupancy theory, 
rate theory, and inactivation theory. 
(i) Occupancy theory 
Biological responses to drugs are, as a rule, graded; they can be measured 
on a continuous scale and, there is a systematic relationship between the dose of a 
drug and the magnitude of the response. Application of the law of mass-action to 
the dose-response relationship was largely done by Clark {126,127J. An observed 
biological effect was assumed to be a reflection of the combination of drug 
molecules with receptors. The magnitude of a response was postulated to be 
directly proportional to the occupancy of receptors by drug molecules. The 
maximal response is assumed to be obtained when all the receptors are occupied. 
(ii) Rate theory 
The central idea in this theory is different from that in the occupancy theory. 
Instead of attributing excitation to the occupation of receptors by drug molecules, 
it is attributed to the process of occupation—each association between a drug 
molecule and a receptor providing one quantum of excitation. The magnitude of 
biological response is proportional to the rate at which drug molecules associate 
with receptor sites. This rate depends on the concentration of free drug, the 
concentration of free receptor sites and the rate constants for association of drug 
molecules with receptor [ 128-130]. 
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(iii) Inactivation theory 
Receptor inactivation theory is based on the two state model originally 
proposed by Katz and Thesleff for ion channels [131].  Kenakinn on his work on 
the Torpedo nicotinic receptor reported that the multimeric receptor exists in 
active and inactive states with ligand binding altering the equilibrium between 
these two states. Receptor inactivation theory reflects a synthesis of both 
occupancy theory and rate theory providing an alternative consideration for the 
study of the receptor ligand interaction. Inactivation theory assumes that RL 
complex is an intermediate "active state" that gives rise to an inactive form of the 
receptor, R', which is part of an RL complex termed R'L [ 132] 
k, 
[R] + [L] 	[RL] 
k, 	 k2 
[R'L] 
where R stands for receptor and L for ligand, and k's being corresponding rate 
constants. 
Classes of amphiphilic drugs include analgesics [ 133], 	antihistamines 
[ 134], local 	anesthetics [ 135-140], tricyclic antidepressants [ 141-145], 
phenothiazine [146-153] and benzodiazepine [154] tranquillizers [155-158], 
peptide [ 159] and non-peptide [160,1611  antibiotics [ 162-164], anticholinergics 
[ 165], [3-blockers [ 166], non-steroidal anti-inflammatory drugs [ 167], anticancer 
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drugs [168]. Many of these drugs contain one or more (condensed or not) aromatic 
nuclei, while others are of peptide nature. A great deal of data on the surface 
active properties of drugs can be found in the book authored by Attwood and 
Florence [169], and in other reviews [170-172]. 
Surface active drugs of quite different chemical structure are reported to 
self-associate and bind to membranes, causing disruption and solubilization, in a 
surfactant-like manner. Depending on the kind of drug, the self-association of 
these drugs is classified into two modes: micellar and non-micellar aggregations. 
Here the micellar aggregation means that a single multimer (micelle) forms above 
the cmc, and non-micellar (stepwise) aggregation means that i-mer is successively 
formed by aggregation of (i—l)-mer and monomer. 
Micellar Solubilzation of Hv'droohobic Druizs 
An important property of micelles is their ability to increase the solubility 
of sparingly soluble substances in water. In this context, solubilization can be 
defined as the spontaneous dissolving of substance by reversible interaction with 
the micelle of surfactant in water to form a thermodynamically stable isotropic 
solution with reduced thermodynamic activity of the solubilized material [173]. 
Micellar system can solubilize poorly soluble drugs and thus increase their 
bioavailability, they can stay in the body (blood) long enough to provide gradual 
accumulation in required areas, and their sizes permit them to accumulate in areas 
with leaky vasculature [174]. 
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The locus of solubilization, i.e., location in the micelle at which 
solubilization occurs, varies with solubilized material as it reflects the type of 
interaction between the surfactant and the solubilizate. Solubilization studies were 
made by different techniques using X- rays diffraction [ 175], NMR spectrometry 
[ 176], UV-visible [ 177-180], and fluorescence [181].  The diffraction studies give 
us changes in the dimensions of micelles upon solubilization, whereas UV, NMR, 
and fluorescence spectra record changes in the environment of solubilizate on 
solubilization. From such studies, Rosen [182] has stated a number of different 
sites in the micelle, Fig. 1.7: (1) on the surface of micelle, at the micelle water 
interface, (2) between hydrophilic head groups, (3) in the palisade layer of the 
micelle between hydrophilic groups and first few carbon atoms of the hydrophobic 
groups that comprise the outer core of the micellar interior , and (4) in the inner 
core of the micelle. 
° i fs 
.ij 's• 
1 	 7 ri 	 4 
Fig. 1.7: Possible loci of solubilization of solubilizate in surfactant micelles. 
Accordingly, hydrophilic drugs can be adsorbed on the surface of the 
micelle (1), drugs with intermediate solubility should be located in intermediate 
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positions within the micelle, such as between the hydrophilic head groups of PEO 
micelles (2) and in the palisade layer between the hydrophilic groups and the first 
few carbon atoms of the hydrophobic group, that is outer core (3) and completely 
insoluble dings may be located in the inner core of the micelle (4) [173,174]. 
The existence of different sites of solubilization in micelle results from the 
fact that the physical properties, such as microviscosity, polarity and hydration 
degree, are not uniform along the micelle [1831. 
The capacity of surfactants in solubilizing drugs depends on numerous 
factors, such as chemical structure of the surfactants, chemical structure of the 
drug, temperature, pH, ionic strength, etc. [174]. Solubilization of drugs in 
micellar solutions has been investigated extensively. Excellent reviews on this 
topic can be found in the literature [169,184]. The benefits of micollar solution as 
drug delivery vehicles arise mainly from the solubilization power of surfactants 
and thus the elimination of dissolution as a rate—limiting step in the process for 
absorption. They may reduce toxicity caused by administering neat drug and 
improve the stability of labile drugs. 
It is important to improve the solubility for poorly soluble drugs because 
these drugs possess low absorption and bioavailability [1851. As solubility is an 
important determinant in drugs liberation, it plays a key role in its bioavailability. 
Any drug to be absorbed must be present in the for n of an aqueous solution at the 
site of absorption [ 186,187]. 
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The hydrophobic micellar moiety of both nonionic and anionic surfactants 
solubilizes nonionizable solutes with poor aqueous solubility [188]. The polarity 
of solute molecules is a major factor in determining the degree of solubilization. It 
has been observed that the solubilizing capacity of ionic and nonionic surfactants 
for solutes that are located in the micellar interior increase in the order of anionic 
< cationic < nonionic. This effect has been attributed to a corresponding increase 
in the area per head group of the series, leading to "looser" micelles with less 
dense hydrocarbon cores that can accumulate more solute [ 189]. 
Hamza and Kata [190] fovnd that the solubilizing power of polysorbates 
was directly related to the alkyl chain lengths with an increase in the chain length 
corresponding to an increase in the solubilizing capacity. Surfactant mixtures are 
also often employed in drug solubilization since such mixtures exhibit high 
solubilization potential for hydrophobic drugs [191-193]. They can lead to 
changes in the size and shapes of micelles, as well as to increase in the amount of 
solubilizate in surfactant solutions [194]. 
Relevance of the Research Problem 
Many pharmacologically active compounds are amphiphilic or hydrophobic 
molecules, which undergo different types of association, and whose site of action 
is frequently the plasma membrane [195]. This membrane affinity is the measure 
of the hydrophilic- hydrophobic interactions in the molecule and can be related to 
the surface activity of drugs. Although the pharmacological effect of drug 
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molecules is usually manifest at low concentrations where self-association is not 
important, it is likely that accumulation of drug molecule at certain sites in the 
body may cause a localized high concentration resulting in aggregation and 
subsequent changes in biological activity due to decreased transport rates or 
decreased ability to pass through biological barriers [169]. 
A most common challenge faced by pharmaceutical scientists as well as 
industry is to design and develop drugs with good aqueous solubility while 
simultaneously retaining potency and selectivity [196]. The absorption properties 
(which cause also bioavailability) of these compounds are influenced by their 
physico-chemical and biological properties. A number of methodologies have 
been adopted to improve the aqueous solubility (and hence bioavailability) of 
drugs. This problem can be overpowered by the use of mixed micelles of drug— 
surfactant or surfactant—surfactant. Drug delivery systems which have attracted 
much attention for their potential to improve the pharmacological properties of the 
drug include nanocapsules [197], cell ghost [198], liposomes [199] and micelles 
[zoo]. 
A mixed acophiphile system can exhibit surface and colloidal properties 
different from those of pure individual components. Nonideal mixing of 
amphiphilic components often causes synergism in the properties of the mixtures 
that may be exploited in their applications. As a result, mixed micelles are 
commonly used in pharmaceutical formulations, in industries, and in enhanced oil 
recovery processes. 
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Keeping the above in mind, we have examined the following aspects: (i) 
mixed micellization study of surfactants with amphiphilic drugs, (ii) solubilization 
of a hydrophobic drug (Phenytoin) in surfactants. 
In order to understand the effect of additives on the association behavior of 
amphiphilic drugs, we have also determined their cmc in presence of various 
concentrations of additives. 
The U.V. spectroscopic technique was used to evaluate the solubilization of 
Phenytoin in surfactants. 
Layout of the Thesis 
This thesis consists of the following four chapters: 
Chapter-I: General introduction 
Chapter-II: Experimental 
Chapter-III: Studies of Amphiphilic Drugs in Presence of Surfactants & Salts 
l'his chapter is divided into two parts, i.e., 
(a) Drug—Surfactant Systems 
(I) Studies with cationic surfactants 
(II) Studies with anionic surfactants 
(III) Studies with nonionic surfactants 
(b) Drug—Salt Systems 
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Chapter-IV: Solubilization of Phenytoin (PHT) by Cationic Gemini Surfactants 
(16-s-16 and 14-s-14, s = 4,5,6) and the Binary Mixtures with Nonionic 
Surfactants 
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Chapter-II 
pperimenta( 
Materials 
All the chemicals used throughout the whole study are listed in 
Table 2.1. The Table also includes their abbreviated names, structural formulas, 
sources. and purities. 
Preparation of solutions 
The water used to prepare solutions was distilled twice over alkaline 
KNlnO4 in all-glass (Pyrex) distillation setup. Specific conductivity of the 
double distilled water Was in range (1-2) x 10-6 S cm-'. Special care was 
observed for cleaning the ;glass wares with chromic acid, then with water, and 
finally by rinsing with double-distilled water. Hygroscopic drugs (NOT, CLP) 
were stored in desiccators. ADP was kept in a refrigerator (at 4 CC). NOT also 
photosensitive, so it was stored in desiccators at a dark place (wrapped in 
aluminum toil). 
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Instrumentation 
Surface tension measurements 
the surface tension (y) of the aqueous surfactant solution was measured 
by a du Nouv tensiometer (Hardson & Co.. Kolkata) at - 30 C temperature 
using a platinum ring. The tensiometer was calibrated against water. In an 
experimental run, the y at each mole traction was measured by successive 
addition of concentrated solution of the mixture in pure water at 30C and the 
surface tension was measured attar proper and thorough mixing and 
equilibration. 
In order to determine the values of critical micelle concentration (emc), 
two linear fits were used for each of' the isotherms. "l'he first line was fitted to 
the interval of concentration characterized b linear decrease of the surface 
tension and the second one to the region of concentration with nearly constant 
surface tension. The cmc Values Were obtained trom the break point of the 
surface tension vs 100 C curve. The accuracy on the individual surface tension 
reading is approximately 0.5 mNm'' 
JJ 
Spectrophoton tric measurements 
The solubility of P1-IT was measured in different surfactant solutions 
with varying concentrations. Excess amounts of PI IT were added to vials 
containing 3 mL of the surfactant solutions to ensure maximum solubility. The 
sample vials having 5 mL capacit\ were scaled with screw caps fitted with 
Teflon-lined septa to prevent any loss. These samples were then agitated with 
magnetic pieces for a period of 48 h on a magnetic stirrer at a temperature of 30 
(±0.5 'C). The solutions were subjected to centrifugation at 15000 rpm to 
remove the undissolved PITT. The concentration of soluhilized PHT was 
determined spectrophotometrically with a Shimadzu spectrophotometer (Model 
UV-1650) following appropriate dilution of an aliquot of the supernatant with 
the corresponding, surfactant concentration. The surfactant concentration was 
kept the same in both the reference and the measurement cells to eliminate the 
effect of surfactant on UV-absorbance. The solubility of PHT at each surfactant 
concentration was determined at 215 nm. 
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'H NMR measurements 
'H NMR spectra of the synthesized gerninis were recorded on 300 MHz 
Bruker Cryomagnet spectrometer (Central Drug Research Institute, Lucknow) 
in case of 16-s-16. (s = 4. 5. 6) and 40U \IHz Broker Avance 11 400 NNIR 
spectrometer (Sophisticated Analytical Instrumentation Facility. Pan_jab 
University. Chandigarh) in case of 14-s-14. (s = 4,5,6) in CDC13 with 'H 
chemical shifts relative to internal TMMMS. 
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Table 2.1: Name and structural f orm uulas of 'the chemicals used. 
Name 
	
Abbreviation Structure/ Formula 	make 
	
% Purity 
(a) Amphiphilic Drugs: 
Adiphenine hydrochloride 
(pK a = 7.92) 
ADP Sigma 
(USA) 
NO 
° 
99 
Nortriptyline hydrochloride 
	
NOT 
	
Sigma 
(PK, = 9.4)2 
	
(USA) 
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Cloinipramin hydrochloride 	CLP 
(pKa = 9.4)
2 
C 
Sigma rKIIiI 	(USA) Il 
HGI 
(b) Hydrophobic Drug: 
Phenytoin 
	
pill 
	
H 
	
Sigma 	= 99 
(pKa = 8.3)) 0 	N-H 
	(USA) 
(c) Surfactants; 
1 ; 4-Bis(~V-hexadecyl-4V, :1V- 	16-4.16 	CI6H33 (CH3)2 N- (CH,)4N-- 
	Self- 
dimethylammonium) butane (CH3): C16 H3; 2 Br 	synthesized 
dibromide 
1, 5-Bis(N hexadecyl-iV, N- 	16.5-16 	C16 H3, (CH3)2 N- (CH,)S N 
	
Self 
dimethylammonium) pentane (CH1)2 C16 H33 2 Br 	synthesized 
dibromide 
59 
1.6-Bis(iV-hexadecyl•N. N- 	16-6.16 	C16 H II (CH3)2 N' (CH2)6 N`- 	Self 
dimedhylammonium) hexane (C1I3 ), C161133 2 Br 	synthesized 
dihromide 
Tetradecyltrimethylanimonim TTAB 
bromide 
Cetyltrimethylammonium 	CTAB 
bromide 
CH3(CH,)13 N'(CH3)3 Br 
CN3(CH,)15 N+(CH3)3 Br 
Self- 
synthesized 
Self- 
synthesized 
Self- 
synthesized 
Sigma 	> 99 
(USA) 
Merck 	> 99 
(Germany) 
1, 4-Bis(~\'-le(radecyl•,Y.,1'- 	14-4-14 	C,BH,y (CH;) 'd' (CH2)4N'- 
dimethylammonium) butane 	 (CH3 )2 C14 H29 2 Bf 
dibromide 
1, 5-13is(N-leeradecyl-,V. ;V- 	14-5-14 	C14 H>y (CH;), N+ (CH,)5N'- 
dimethylammonium) butane 	 (CH;), C,4R29 2 Br 
dibromide 
1, 6-Bis(N-tetradecyl-N, N- 	14-6-14 	C14 H29 (CH3)2 N+ (CH2)6N'- 
dimethylammonium) hexane 	 (CH3)2 C14 H29 2 Br 
dibromide 
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= 97 Sodium cholate 	NaC 	 Sigma 
	
`oNp 	(USA) 
L. 	H 
Sodium deox4cholate 	NaDC 	 ~ '''-, G 	Sigma 
I ' 	0 N 	(Germany) 
tIQ~ ' , 
Sodium taruocholate 	NaTC 	 ° 	Sigma 
'~s•o' 	(USA) 
N 	0 
NN 
NU' H 'UH 
Polyoxyethylene sorbitan 	Tween 40 	 Koch —Light 
monopalmitate 	 (England) 
(T40) 
Polyoxyethylene sorbitan 	Tween 80 	 LOBA 
monooleate  
(T80) 	 (India) 
=97 
=97 
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S~iiperonic 	 P85 	 Sigma 
(Germany) 
synperonic 	 F108 	 Fluka 
(Germany) 
Sodium salicylate 	NaSal 	Coo Na' 	 Merck 	99.5 
	
OH (India) 0 
Sodium benzoate 	NaBenz 	COO Na 	 Merck 	99.5 
(Germany) 0 
Sodium losylate 	NaTos 	+ 	 Fluka 	70-80 
S03 Na 
(Switzerland) 
0 
CH3 
(d) Electrolytes: 
Sodium chloride 	NaCI 	-- 	 BDH 	> 99.9 
(England) 
62 
Sodium bromide 	Na13r 	— 	 LOBA 
	
99 
Chemie 
(India) 
Potassium chloride 	KCI 	 RI)H 
	
91,8 
(India) 
Potassium bromide 	003r 	- 	 Merck 
	
99 
(India) 
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l llu rers IIandhtu'h (IC! /)i urnI►►zc iitisciIen P atis.11M. Albino; (Ed.). Berlin 11999). 
` R. (i. Katzung. Basin and ('finical Phormacolo'. 9" ed.. M1c(ir ,m I lilt. New York (2004). 
' S. 1'. Annul and M. I. Make. J. Phurnl. Sd i.. X7.1434 (I 9b). 
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Synthesis of getnini surfactants 
There are two main factors hich are important in their preparation: one 
is synthesis and other is pUrllicatiOn. I he his(gUaternary ammonium) 
surfactants were synthesized by adopting the tollo ing scheme and the 
procedure outlined in reference (l I. 
:A 1 :2.1 equivalent mixture 0f - corresponding a,rw-dibromoalhane with N. 
,V-dimethvlalkvlamine in dry ethanol was retluxed (at 80 °C) for 48h. The 
progress of reaction was monitored using TIC technique. At the end, the 
solvent was removed under \ accum from the reaction mixture and the solid 
thus obtained was recrystallized several times from hexane/ethyl acetate 
mixture to obtain the compound in pure firm. The overall yield of the 
surfactants ranged from 7U-90° 
Retlux, dr\ ethanol 
Br (C.'H>)., Br + 2C,H,,,-IN(CH;)2 
48 it. 8) '(: 
CH11 +iICII)N 	(Cl I2)s—N-(CII,),C„H,,,,I.2Br 
(s=4.5.6) 
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The surfactants were characterized by 'H NNIR and cmc detennination. 
Pertinent details are given below. 
(1) 1, 4-bis(N-tetradecvl-N, N-dimethvlammonium)butane dibromide (14-4-14) 
(Fig.2. 1) 
CH3 	 CH3  
	
a b+c d e h I + 	g g i ,+ h e d b+c a 
CH3(CH,)i0CH,CH,CFIz N—CH,CH2CH,CH2  N—CH,CH2CH2(CH2),0CH3  
Br 	I I 	Br" 
CH3 	 CH3  
I f 
(2) 1, 5-bis(N-tetradecvl-N, N dimethylammonium)pentane dibromide (14-5- 
j4)jFig.2.2) 
CH3 	 CH3  
a b 	C e h 	I + i 	f d f i 	(+ h e c b 	a 
CH3(CH 2)l0CfI.CH,2CH 2—N—CH 2CH 2CH,CH2CH 2—N--CH,CH2CH 2(CH,)10CH3  
BT CH3 	 3 CH Br 
(3) 1. 6-bis(N-tetradecyl-N, N-dimethylammonium)hexane dibromide (14-6-14) 
(Fig.2.3) 
CH 3 	 CH3  
a b 	c e h I + i f d d Ii 	he c b a 
CH I (CH,)10CH:CH,CH,—N—CH,CH,CH,CH,CH ZCH:—N— CH ZCH.CH Z (CH Z ) icCH 3  
Br CH 	 CH3 Br t  
(4) 1. 4-bis(X-hexadecvt-N, N-dimethylammonium)butane dibromide (16-4-16) 
(Fig.2.4) 
H 3 	 Fly 
a b+c J e h ç+ i g g i + h e d b+c a 
CH3(CH,)12 CH,CF{ Z CH 2 —N —CFJ 2 CH.CH 2CH 2—N —CN2CN 2 CH 2(CH 2 )1 2CH 3  
Br 	` 	 Br 
CH 3 CH;  
I 	 r 
(5) 1. -bis(.\hexadecvI-N. N-dimethylammonium)pentane dibromide (16-5-
j_( Fig .2.5) 
h 
CH3 	 CH3 
a b-c e 	f i 	I + j 	g d 	g i 	,+ i 	f e b+c 	a 
CH3(CH,)12 CH 2CH1CH.—N—CH2CH2CH 2CH 2CH 2—N— CH2CH2CH2(CH2)12CH3 
	
Br C113 	 CH3 Br 
(6) 1, 6-bis(N-hexadecvl-N, N-dimethylammonium)hexane dibromide (16-6- 
16) 
(Fig.2.6) 
h 	 h 
CH3
T 
H3 
a 	b+c 	d f i 	I + j 	S 	e 	e 	g j 	~. i 	f d 	b+c 	a 
CH3(CH:)1 ,CH2CH ZCH,— i — CH,CHZCH ZCH ZCH 2CH2-- —CHZCHZCHZ(CHZ)12CH3 
Br 0113 	 CH3 Br- 
The 1 H NMR data for the indicated groups a, b, c, d, etc., are given in Table 
"7 
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Fable 2.2: ' // .V vIR data for in-s-in gemini .siirfKtaits 
Surfactant Group O(ppm ) Number of Protons 
14-4-14 a 0.864-0.878 6 
h+c 1.255-1.351 40 
d 1.752 4 
L 2.068 4 
f 3.311 12 
g 3.419-3.461 4 
h 3.613 4 
3.789 4 
14-5-14 a 0.863-0.897 6 
b 1.355-2.556 40 
c 1.582-1.615 4 
d 1.733 2 
e 2.037-2.u74 4 
f 2.953 a 
3.-87 12 
h 3.512-3.554 4 
i 3.8l i-3.833 4 
14-6-14 a 0.863-0.897 6 
b-c 1.2 4-1.353  44 
d 1.557 4 
e 1.724 4 
f 1.973 4 
2.844  
h 3.396 4 
3.509-3.71 I 4 
cancel... 
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16-4-16 	a 0.883 6 
b+c 1.257-1.344 48 
d 1.754 4 
e 2.084 4 
f 3.308 12 
g+h 3.431 8 
i 1.000 4 
6-5-16 a 0.858 6 
b-c 1.257 48 
d 1.617-1.663 2 
e 1.728 4 
f 1.854 4 
g 2.073-2.126 4 
h 3.349 12 
i 3.445-3.501 4 
j 3.853-3.909 4 
16-6-16 a 0.857-0.900 6 
b+c 1.255-1.350 48 
d 1.580-1.618 4 
c 1.715 4 
f 1.995 4 
g 2.252 4 
h 3.113 12 
3.284-3.712 4 
j 3.903 4 
ego no 0 	 - 	 s 	 ~~e 	 aim O P r .SON. 	r ti r1 N 	 b Wi 	 M NOon ./ 	 a O V r `o O r runt. 5Cc 
M 	X 14
7 T 
	 N 	 0 17 
4.0 	3.S 	3.0 	2.5  
Fig. 2.1: ! H NMR spectrum of 14-4-14 in CDC13. 
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Fig. 2.2: 'H 1VMR spectrum of 14-5-14 in DC13. 
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Fig. 2.3: 'H NMR spectrum of 14-6-14 in CDC13. 
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Fig. 2.4: 'H ., vMR spectrum of 16-4-16 in CDC13. 
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Fig. 2.6: 'H IS/MR spectrum of 16-6-16 in CDC13. 
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Reference: 
[ 1 ] R. Zana, Adv. Colloid Interface Sci., 97, 203 (2002). 
76 
Chapter-III 
Studies of ~l iphiphi&tc Drugs in Presence of 
Surfactants e' Salts 
(-a) Drub —Surfactant Systems 
(I) Studies with Cationic Surfactants 
Introduction  
Amphiphilic systems have generated a great deal o Interest mainly due 
to their wide-spread applications in diverse fields. The functions and properties 
of amphiphiles are interesting because they form various types of assemblies 
depending on their concentration and environmental conditions such as pH, 
temperature, type and concentration of additives [1,2]. 
When an amphiphile is dissolved in water, it disrupts the interaction 
among the water molecules distorting the water structure. This results in an 
increase in free energy of the system. This can be overcome by the association 
of the amphiphiles into micelles. Micellization can, thus, be considered as an 
alternate mechanism to adsorption at the interfaces. The energetics of 
adsorption and micellization are usually discussed in terms of various forces 
operating among the amphiphiles and with the solvent molecules, like 
attractive forces between the hydrophobic parts, dispersion, van der Waals and 
electrostatic interactions between the head groups and hydrophobic interactions 
among the amphiphiles and water molecules. All these factors can be changed 
with the change in type and structure of amphiphiles which eventually affects 
the process of micellization as well as of adsorption. 
In this respect gemini surfactants are worth mentioning. As compared to 
conventional surfactants, gemini surfactants are made up of two (or more) 
amphiphilic molecules joined at the level of head groups by a spacer [3]. These 
surfactants have 10 to 100 times lower critical micelle concentration (cmc) than 
the conventional homologs. It is known that the spacer chain length largely 
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affects the surface and solution properties of these surfactants [4]. Due to their 
high molecular weight. their skin penetration is expected to be low. Some 
cationic gemini surfactants, besides their surface activity, also show 
antibacterial properties [5,6]. In addition to this, as the gemini surfactants have 
been found more efficient than their conventional single chain counter part in 
their interaction with serum albumin [7], they may be used more effectively in 
the renaturation of proteins produced in genetically engineered cells via the 
artificial chaperone protocol. 
One major problem of pharmacology is that no drug produces a single 
effect. The primary effect is the desired therapeutic effect. Secondary are all 
other effects beside the desired effect which may be either beneficial or 
harmful. Generally, a concentration higher than the amount required for 
therapeutic effect is present in formulations. If too high a concentration is used, 
the side effects would be more. Use of drug with a carrier reduces these 
harmful effects. The most commonly used carriers are polymers, liposornes, 
niosomes, micelles and lipoproteins. Micelles have an advantage as they are 
easy to prepare, have long shelf-life and reduce the amount of both drug and 
carrier, making them cost effective and less toxic [8,9]. As conventional 
surfactants have higher crnc values than geminis, micelles of conventional 
surfactants may disintegrate upon introduction in large blood volume. Hence, 
geminis provide a better option as drug carrier. Towards finding new and`or 
improved applications, a way of changing the properties of an amphiphile is to 
mix it with a surface active compound so that synergism can take place. A 
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mixed amphiphile system thus formed can exhibit surface and colloidal 
properties different from those of the pure individual components. The 
effectiveness of mixed systems is related to interactions among different 
components which can increase or decrease the synergism in the system. The 
magnitude and nature of these interactions as well as the composition of mixed 
monolayers and mixed micelles can be determined employing different models 
[ 1,10-16]. Synergism in the properties of binary mixtures that may be exploited 
in their application in industrial preparations and pharmaceutical formulations 
may he due to non-ideality of nixing in binary mixtures of amphiphilic 
compounds [ 17]. 
Adiphenine hydrochloride (ADP) is an antieholinergic which is used to 
treat Parkinson's disease, gastrointestinal and respirator) disorder Its use may, 
however. result in increased heart rate and, if taken in significant amount, a 
toxic reaction may take place in the body. Nortriptylinc hydrochloride (NOT) 
and clomipramine hydrochloride (CLP) are tricyclic antidepressants. these 
drugs are used For the treatment of major depression. I fence, these drugs should 
be used with a carrier in order to reduce the side effects. Keeping all these facts 
in mind, we have performed tcnsiomctric measurements on ADI . NOT and 
CLP—cationic surfactant mixtures. Various parameters are evaluated using 
Clint s. Rubingh's and Motomura's approaches. Adsorption behavior of mixed 
monolavers was also studied using Gibbs equation, the surfactants used are 
the so-called alkanediyl—a.m—bis(dimethylalkytammonium bromide), m-s-m 
type cationic geminis with in — 14 or 16 and s = 4. 5. 6 and their monomeric 
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counterparts, i.e., tetradecyltrimethylammonium bromide (TTAB) and 
cetyltrimethylammonium bromide (CTAB) and the drugs used are ADP. NOT 
and CLP. 
Results and Discussion 
Mixed micellization of drug-cationic surfactants 
Table 3.1 records the cmc values of pure components and the effect of 
mole fraction of the added surfactants (a,) on the cmc of drug—surfactant 
mixtures (evaluated on the basis of tensiometric measurements, Figs. 3.1 to 
3.9). The cmc of pure surfactants agree well with literature [ 18,19,20]. 
Also the values of cmc of pure drugs obtained in this work are in 
accordance to those reported in literature [21] except for ADP. The value of 
crnc for ADP is lower than values determined from light scattering (LS) 
measurements. This maybe due to the difference in techniques used. Literature 
also contains similar results of lower tensiometric values than LS values 
[22,23]. The cmc values of drugs follow the order: ADP > CLP = NOT. The 
tail part of ADP is short (hence less hydrophobic) and the head part is very 
rigid. Both these factors decrease the tendency of ADP to micellize. NOT and 
CLP are structurally similar and difference in their cmc values is due to the 
attached substituents. Al! the drugs have Cl- ion as cormterion. The tone-pair 
of electrons on the ring nitrogen of CLP undergoes resonance with the aromatic 
rings. This results in tautomers with zwitterionic character which decreases the 
hydrophobicity of the drug. However, presence of a Cl atom at Rz position and 
an extra CH;  group in CLP (as compared to NOT) increases the hydrophobicity 
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of the drug. Hence, the overall hydrophobicity of CLP comes out to be almost 
equal to that of NOT and the cme values of the two drugs are almost equal. At 
the mole fractions studied, cmc decreases with the addition of conventional as 
well as gemini surfactants, this suggests that the mixed micelles are formed in 
the solution and the surfactants are penetrating into the micelles formed by the 
drug molecules. As gemini surfactants contain two hydrophobic chains, they 
increase hydrophobic interactions and enhance the tendency of drugs to form 
nacelles to a larger extent than the conventional surfactants. The cmc values of 
the mixed systems usually fall in between the values of pure components. Also 
in our systems the values of cmc of drug-surfactant mixtures are in between the 
pure components. This means that the mixed micelles are formed due to 
attractive interactions among the two components. 
The ideal-nonideal behavior of mixed systems can be examined by 
Clint's model [10). 
1 	a 
cmc* 	cmc~ 
(3.1) 
Here a; and cmc; are the mole fraction and crnc of i" component. The cmc* 
values decrease with the mole fraction of the surfactants in the solution. As the 
mole fraction of surfactants in the solution is low the cmc* values remain close 
to the cmc of pure drug. The cmc* values are greater than cmc value. The 
difference between the two values gives the extent of non-ideality in the 
system. Lower cmc values indicate that the mixed micelles are formed through 
attractive interactions. 
Si 
Nonideal behavior can be quantitatively understood by Rubingh's 
model [ I 1 ]. Rubingh's model is an optimization algorithm toward the cmc of 
mixed system from the cmc of pure components. Their mole fractions and 
interaction parameters are optimization parameters. This model considers 
mixed micelles as a regular solution. The equations are as 
(X 1")2 ln[(cmccz, / X,'" cmc,] 	_ 1 	 (3.2) 
(1—X;°)2 ln[(l—a,)cmc/(1 —X1 )cmc,] 
and 
„ 	 In [(a, cmc) /(X,"` cmc, )] —  
(1—X'")2  
(3.3) 
The values of X; (Tables 3.2 to 3.4) increases with the increase in surfactant 
content. With the increase in spacer chain X,°" decreases marginally. 
The X; values show that both drug and surfactants have equal 
contribution in mixed micelle formation. This shows that the surfactants are 
more hydrophobic than the drugs and the micelle formation is more 
spontaneous for surfactants. 
The mixed micelle formation, due to the attractive and repulsive 
interactions, are indicated by negative and positive J3'" values, respectively, 
while a value close to zero refers to an ideal behavior [24]. 
The negative values of 13"  means that the attractive interaction between 
drug and surfactant is stronger than the individual components. 
Mole fraction of surfactants in mixed micelles at ideal mixing conditions, 
X,'° . is given by 
X ,d = 	a, Mc, 	 (3.4) 
a, cme, +a2 cmc, 
X;" values increase with the concentration of surfactants and decrease with the 
spacer length's increase. Both X,'" and X,1° are lower for 14-s-14 series as 
compared to 16-s-16, which is understood by the fact that 14-s-14 series 
surfactants are less hydrophobic than 16-s-16. Nonideality in the mixed 
micelles can be explained by deviation of X,'" from the corresponding X,' 
values. Tables 3.2 to 3.4 show the variation of X," and X. Lower values 
than  the corresponding X;" indicate that the mixed micelles are rich in drug, 
while higher X,'" than corresponding X," indicate that mixed micelles are rich 
in surfactant and X, values close to X(" indicate ideal mixing. 
The values of activity coefficients, f" and f2' were calculated by 
equations (3.5) and (3.6) and are given in Tables 3.2 to 3.4 
I" =exp {l'"(t-X; )2 } 	 (3.5) 
f' =&pv r(x; )'} (3.6) 
All the values are less than unity indicating non-ideality in the mixed systems. 
These values were used to calculated excess Gibb's energy of micellization, 
AG, by the relation (91 
AGu =RT[X,"lnf"+(l—X,)lnf2'] 	 (3.7) 
The excess Gibbs energy is a measure of the interactions between the two 
components in [nixed micelles with reference to the interactions between 
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molecules in micelles formed from respective surfactants. TheaG~„ values 
(Tables 3.2 to 3.4) come out to be negative and the magnitude increases with 
increase in surfactant concentration, suggesting that the mixed micelles are 
more stable than the micelles of pure components. 
The standard Gibb's energy of tnicellization 4G° of the pure and mixed 
systems was calculated using the relation: 
AGRTInxmc 	 (3.8) 
where X,,, is the cmc expressed in mole fraction units. The values of iG~,' , 
given in Tables 3.2 to 3.4, are negative and their magnitude increases with the 
mole fraction of surfactants. As is clear from cmc values and structure of drugs, 
the process of micelle formation is more spontaneous for surfactants. The 
formation of mixed micelles is more spontaneous than the micelle formation of 
drug. 
Adsorption at the air/water interface 
Various theories have been developed and applied to study the 
formation and behavior of monolayers formed in mixed systems [1,12, 13]. The 
interaction parameter, /3°, for the mixed monolayers and the composition of 
mixed monolayers (Y) are evaluated using the equations 
In (a, conc./X ;° cone, 
— 	
(3.9) 
and 
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(.l' ), In (a. CO,tc . .l 	com. , 	-  
(3.1U) 
1' (1- .,° )~ [in (1 - a, )conc:'(l - X )conc.] - 
where a; is the mole traction of surfactant in the solution concl, cone, and 
cone are the molar concentrations in the solution of surfactants, drug and their 
mixture respectively, required to produce a particular % value (in this 
calculation ;,- 45 mNm'I is fixed). 
The fl values become more negative, which show stronger attractive 
interaction at the solution air interface. The /3am values are more negative than 
13"' , which implies that the interaction at the solution/air interface are stronger 
than in mixed micelles. This is due to the steric factor \\hich is more important 
in micelle formation than in nl0n0laytr formation at a planer interface. 
Fhe X/' values, calculated by using equation (3.10) and as shoe n in 
Fables 3.5 to 3.7, were turnci to be higher than X," Values, suggesting that 
more surfactant is present in mixed nionola\ er a, in the mixed micelles clue to 
the more repulsion between drug and surfactant moieties. The results also 
indicate that increase in hydrophobic chain length of the surfactants (both 
geminl and conventional) increases their contribution in mixed monola\er 
tornlatlon. although margin-idly. 
The values of 13^ and .t i" arc u;ecl to calculate the Value of activit\ 
coelticicnN of the two components. 1 and t.' as 
1•I 1,' = exp r (i-.1" ) j 	 (3.11) 
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Iz = exp p (Xi° )2 } 	 (3.12) 
The values of J and J , given in Tables 3.5 to 3.7, are always less than unity 
indicating non-ideality in the system. 
The surface excess concentration at the surface saturation, T,, is given 
by equation [25] 
1 dY } 	 (3.13) 2.303nRT ldlogC 
The minimum surface area per molecule (Ara ) is given by: 
1 
Amin =pj r 
 (3.14) 
where n is introduced to allow simultaneous adsorption of cation and anion. 
The value of n is used as 2 for pure drug and conventional surfactants, 3 for 
gemini surfactant and 4 and 5 for drug-conventional and drub genuni 
mixtures. Other symbols have their usual meanings. Tables 3.5 to 3.7 bear the 
values of r,. and A, for pure components and drug- surfactant mixtures (see 
Figs. 3.10 to 3.15). As the concentration of surfactants increases in the solution, 
surface excess also increases. In the absence of surfactants the drug molecules 
experience more steric as well as electrostatic repulsions and they try to remain 
far apart from each other. However, as the surfactants are added into the 
solution they intercalate between the drug molecules and repulsion decreases. 
As a result, an increase in I,n„ takes place. A„,;,, follows a trend opposite to 
that of ... 
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The molar free energy at the Ill<l\Illllllll adsorption attained at cinc. G„ra• 
is calculated using equation (3.15) x'61: 
;\• 	 (3.15) 
G,,, is the minimum free energy of the given surface with fully adsorbed 
amphiphile molecules. Lower the value of' the tree ener~7v. more stable is the 
surface formed. Generally with the increase in mole fraction of surfactant. G,,,,,, 
value decreases (Tables 3.5 to 3.7). 
I`he standard Gibbs energ\ of adsorption, AG., is related to AG,;; 
through the relation [27} 
(3.16) 
\where T. ,, is the surface pressure at the cHrc. i.e.. , ,. 	- v 	( y„ and 	are 
the surf.icc tensions of pure solvent and mixed system at cmc, respectively). 
The values of AG,'1 (presented in Tables 3.5 to 3.7) are all negative and the 
magnitude is greater than .\G , , , I his means that amphiphiles first try to 
accumulate at the interface and after its saturation these molecules form mixed 
micelles. 
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Table 3.1: Variation of cmc and cmc* for mixed drug- cationic surfactant 
systems. 
Mole ADP NOT CLP 
fraction cmc cmc* cmc cmc* cmc cmc* 
(MM) (mM) (MM) (MM) ( 	t) (mM) 
0 41.0 20.8 18.48 
16.4-16 
0.00025 13.55 30.02 12.78 17.55 10.57 15.87 
0.0005 9.66 23.07 10.36 15.17 9.65 13.90 
0.001 2.11 16.44 4.20 11.94 2.70 11.14 
0.002 1.55 10.44 2.30 8.38 1.56 7.79 
1 0.028 
16-5-16 
0.00025 12.97 31.06 12.81 17.90 10.95 16.15 
0.0005 10.24 25.00 10.03 15.70 7.78 14.34 
0.001 2.41 17.98 3.15 12.61 2.38 11.72 
0.002 1.73 11.52 1.73 9.05 1.27 8.58 
1 0.032 
16-6-16 
0.00025 13.26 32.30 12.76 18.31 11.10 16.48 
0.0005 9.06 26.64 9.52 16.34 9.93 14.87 
0.001 2.29 19.73 3.33 13.45 4.47 12.44 
0.002 1,36 12.99 2.18 9.94 2.98 9.38 
1 0.038 
0.0125 11.67 25.62 8.64 16.02 5.76 14.62 
0.02 8.55 20.91 5.15 14.01 4.31 12.99 
0.03 6.05 16.79 4.33 12.12 2.15 11.32 
0.04 5.28 14.03 3.12 10.64 1.47 10.02 
1 0.836 
14-4-14 
0.00025 10.03 38.31 10.39 20.09 10.65 17.92 
0.0005 8.15 35.96 8.64 19.42 9.31 17.39 
0.001 5.61 32.16 4.56 18.22 2.18 16.41 
0.002 
1 
3.40 26.26 3.22 16.20 1.82 14.76 
0.146 
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14-5-14 
0.00025 11.21 38.56 11.3 20.16 8.11 17.97 
0.0005 8.75 36.39 9.93 19.55 7.81 17.49 
0.001 6.21 32.71 5.02 18.44 3.16 16.59 
0.002 3.61 27.21 2.22 16.56 1.46 16.58 
1 
0.161 
14-6-14 
0.00025 11.80 38.93 12.63 20.26 9.55 18.05 
0.0005 7.55 37.07 8.61 19.74 9.12 14.48 
0.001 6.88 33.82 3.75 18.79 2.04 12.44 
0.002 3.87 28.78 2.21 17.13 1.43 9.38 
1 
0.192 
0.0125 13.29 36.15 7.28 19.58 5.70 17.51 
0.02 11.75 33.77 6.31 18.91 3.59 16.97 
0.03 12.17 31.03 5.16 18.09 3.40 16.31 
0.04 11.66 28.72 3.45 17.34 1.90 15.69 
1 3.40 
Table 3.2: Various physicochemical parameters (i.e.,X I",XII° , 0'", f/, f'" 
AGe11 and AGm) for mixed ADP-cationic surfactant systems. 
Mole fraction Xi"' XI ~f'" f " /1" AGE AGO 
(kJ mol'') (k.T moi') 
0 -18.2 
16-4-16 
0.00025 0.41 0.27 -3.49 0.29 0.56 -2.1 -20.9 
0.0005 0.47 0.42 -3.62 0,37 0.46 -2.3 -21.8 
0.001 0.52 0.59 -8.32 0.15 0.11 -5.2 -25,6 
0.002 0.55 0.75 -8.09 0.20 0.08 -5.0 -26.4 
1 -36.5 
16-5-16 
0.00025 0.40 0.24 -3.89 0.25 0.53 -2.4 -21.1 
0.0005 0.46 0.39 -3.64 0.35 0.46 -2.3 -21.7 
0.001 0.51 0.56 -8.09 0.15 0.12 -5.1 -25.3 
0.002 0.55 0.72 -7.94 0.20 0.09 -4.9 -26.1 
1 -36.2 
16-6-16 
0.00025 0.39 0.21 -4.09 0.22 0.53 -2.5 -21.0 
0.0005 0.45 0.35 -4.44 0.26 0.40 -2.8 -21.9 
0.001 0.50 0.52 -8.62 0.12 0.11 -5.4 -25.4 
0.002 0.53 0.68 -9.27 0.13 0.07 -5.8 -26.8 
1 -35.8 
CTAB 
0.0125 0.46 0.38 -3.23 0.38 0.51 -2.0 -21.3 
0.02 0.50 0.50 -3.58 0.41 0.41 -2.3 -22.1 
0.03 0.53 0.60 -4.14 0.41 0.31 -2.6 -23.0 
0.04 0.56 0.67 -4.08 0.45 0.28 -2.5 -23.3 
1 -2 L3 
14-4-14 
0.00025 0.36 0.07 -7.43 0.05 0.38 -4.3 -21.7 
0.0005 0.39 0.12 -7.21 0.07 0.33 -4.3 -22.2 
0.001 0.43 0.22 -7.56 0.08 0.24 -4.7 -23.2 
0.002 0.42 0.36 -8.32 0.09 0.16 -5.2 -24.5 
1 -32.4 
90 
14-5-14 
0.00025 0.35 0.06 -7.95 0.05 0.42 -4.1 -21.4 
0.0005 0.39 0.11 -7.07 0.07 0.35 -4.2 -22.1 
0.001 0.43 0.20 -7.32 0.09 0.26 -4.5 -22.9 
0.002 0.47 0.34 -8.26 0.09 0.16 -5.2 -24.3 
1 -32.1 
14-6-14 
0.00025 0.34 0.05 -7.14 0.05 0.44 -4.0 -21.3 
0.0005 0.39 0.10 -7.97 0.05 0.30 -4.8 -22.4 
0.001 0.42 0.18 -7.20 0.08 0.29 -4.0 -22.7 
0.002 0.46 0.30 -8.31 0.09 0.17 -5.2 -24.2 
1 -31.7 
TTAB 
0.00025 0.37 0.13 -5.08 0.13 0.50 -2.9 -21.0 
0.0005 0.40 0.19 -4.86 0.17 0.46 -2.9 -21.3 
0.001 0.41 0.27 -4.19 0.24 0.48 -2.6 -21.2 
0.002 0.43 0.33 -3.89 0.29 0.48 -2.4 -21.3 
1 -24.4 
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Table 3.3: Various physicochemical parameters (i.e., X; ,X 	/3 "' f" f1" 
AGE and dGm) for mixed NO7=cationic surfactant systems. 
Mole X° X~° p^m f f"' AG3S AGO 
fraction (Id mof') (k. mof') 
0 -19.9 
16-4-16 
0.00025 0.29 0.16 -1.81 0.40 0.86 -0.9 -21.1 
0.0005 0.37 0.27 -1.74 0.50 0.79 -1.0 -21.6 
0.001 0.48 0.43 -4.21 0.31 0.38 -2.6 -23.9 
0.002 0.53 0.60 -5.24 0.31 0.23 -3.3 -24.6 
1 -36.5 
16-5-16 
0.00025 0.28 0.14 -1.99 0.36 0.86 -1.0 -21.1 
0.0005 0.36 0.25 -2.09 0.43 0.76 -1.2 -21.7 
0.001 0.47 0.39 -5.62 0.21 0,29 -3.5 -24.6 
0.002 0.52 0.57 -6.65 0.21 0.17 -4.2 -26.1 
1 -36.2 
16-6-16 
0.00025 0.27 0.12 -2.25 0.31 0.84 -1.1 -21.1 
0.0005 0.36 0.21 -2.61 0.35 0.71 -1.5 -21.8 
0,001 0.46 0.35 -5.74 0.19 0.29 -3.6 -24.5 
0.002 0.46 0.52 -4.73 0.25 0.37 -2.9 -25.6 
1 -35.8 
CTAB 
0.0125 0.38 0.24 -2.83 0.34 0.66 -1.7 -22.1 
0.02 0.45 0.34 -4.18 0.28 0.44 -2.6 -23.4 
0.03 0.48 0.43 -4.15 0.32 0.39 -2.3 -23.8 
0.04 0.50 0.51 -4.92 0.30 0.29 -3.1 -24.7 
1 -21.3 
14-4-14 
0.00025 0.27 0.03 -5.15 0.07 0.68 -2.6 -21.6 
0.0005 0.32 0.07 -5.04 0.09 0.61 -2.7 -22.1 
0.001 0.39 0.12 -6.78 0.08 0.36 -4.1 -23.7 
0.002 0.43 0.22 -7.04 0.10 0.27 -4.4 -24.6 
1 -32.4 
om 
14-5-14 
0.00025 0.26 0.03 -4.84 0.0' 0.73 	-2.3 -21.4 
0.0005 0?9 0.06 -4.53 0.10 0.67 	-2.4 -21.7 
0.001 0,38 0.11 -6.3 0.08 (L3) 	-3.9 -23.5 
0.002 0.44 0.21 -8.76 ft06 0.19 	-5.4 -25.5 
1 -32.1 
1.1-6-14 
0.00025 0.23 0.03 -4..- 0.u7 0.79 	-2.O -21.1 
0.0005 0.31 0.05 -5.47 ().U7 0.60 	-2.9 -22.1 
0.001 0.39 0.10 -8.05 0.05 1).29 	-4.8 -24.2 
0.002 0.43 0.18 -9.05 0.05  0.19 	-5.6 -25.5 
1 -31.7 
TTA11 
0.01 25 0.34 O.U,  - 5.7$ 0.il$ 0.52 	-3.3 -22.5 
0.02 0.37 0.11 -5.72 0.1(3 0.4' 	-3.3 -22.9 
0.03 0.39 0.16 -6.08 0.11 0.39 	-3.7 -23.4 
0.04 0.42 0.20 -7.29 (1.1)') 0.27 	-4.5 -24.4 
-24.4 
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Table 3.4: Various physicochemical parameters (i.e., X;" X<" 	/3", f,,, 
AG`', and AG,,',) for mixed CLP--cutionie stirfirctunt systems. 
Mole X", X" /3,,, 1 ,,, f ''  
fraction (kJ mole ) (kJ rno1 	) 
0 -20.2 
16-4-16 
0.00025 0.30 0.142 -2.33 0.317 0.812 -1.2 -21.6 
0.0005 0.35 0.248 -1.73 0.487 0.806 -1.0 -21.8 
0.001 0.48 0.398 -5.79 0.203 0.271 -3.6 -25.0 
0.002 0.52 0.569 -6.69 0.214 0.164 -4.2 -26.4 
1 -36.5 
16-5-16 
0.00025 0.29 0.126 -2.35 0.300 0.826 -1.2 -21.5 
0.0005 0.37 0.224 -2.87 0.325 0.669 -1.7 -22.4 
0.001 0.47 0.366 -6.56 0.138 0.235 -4.1 -25.3 
0.002 0.51 0.536 -7.75 0.156 0.133 -4.9 -26.9 
1 -36.2 
16-6-16 
0.001)25 0.28 0.110 -2.59 0.261 0.816 -1.3 -21.5 
0.0005 0.33 0.196 -2.06 0.396 0.799 -1.2 -21.7 
0.001 0.45 0.327 -4.32 0.264 0.452 -2.7 -23.8 
0.002 0.50 0.494 -4.61 0.314 0.317 -2.9 -24.8 
1 -36.8 
CTAB 
0.0125 0.40 0.219 -4.24 0.216 0.509 -2.6 -23.1 
0.02 0.44 0.311 -4.72 0.232 0.394 -2.9 -23.8 
0.03 0.48 0.406 -6.73 0.161 0.214 -4.2 -25.6 
0.04 0.50 0.479 -7.77 0.141 0.146 -4.9 -26.6 
1 -27.3 
14-4-14 
0.00025 0.25 0.031 -4.55 0.075 0.762 -2.1 -21.6 
0.0005 0.29 0.060 -4.29 0.112 0.705 -2.2 -2 I.9 
0.001 0.41 0.112 -9.59 0.036 0.199 -5.8 -25.6 
0.002 0.44 0.202 -9.11 0.057 0.173 -5.7 -26.0 
1 -32.4 
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14-5-14 
0.00025 0.28 0.028 -6.08 0.044 0.612 -3.1 -22.3 
0.0005 0.31 0.054 -5.29 0.079 0.608 -2.8 -22.3 
0.001 0.40 0.103 -8.20 0.050 0.278 -4.9 -24.6 
0.002 0.41 0.187 -10.17 0.041 0.140 -6.3 -26.6 
1 -32.1 
14-6-14 
0.00025 0.29 0.024 -5.51 0.048 0.690 -2.7 -21.8 
0.0005 0.35 0.046 -4.80 0.084 0.680 -2.4 -21.9 
0.001 0.47 0.088 -10.49 0.026 0.170 -6.4 -25.7 
0.002 0.52 0.162 -10.57 0.034 0.135 -6.5 -26.6 
1 -31.7 
TTAB 
0.0125 0.35 0.063 -6.58 0.060 0.457 -3.7 -23.1 
0.02 0.39 0.098 -7.89 0.053 0.301 -4.7 -24.3 
0.03 0.41 0.141 -7.57 0.075 0.280 -4.6 -24.4 
0.04 0.44 0.182 -9.57 0.050 0.159 -5.9 -25.9 
1 -24.4 
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a Table 3.5: Jntc' 'Jclili L ompositi H ( .\ 	?f ~ t!('/;OH ,'1i,!'  11JTC'1P7' (/1 ), actiVltl' 
coef ficients (f 
( ) in mixed mono/aver and .SII!'JClCP properties ('rmu 	G p jn 
and AG ) for mixed ADP-cationic swfiietant systems. 
Mole 
fraction 
X; /J ° i f ,n r'i" .106 
(mol m-') 
A...» 
(A') 
Gm,„  
(kJ mold ) (kJ mol4) 
0 1.734 95.75 24.8 -35.1 
16-4-16 
0.00025 0.41 -5.42 0.19 0.35 0.923 179.91 42.3 -56.0 
0.0005 0.49 -6.38 0.19 0.22 1.021 162.5.1 36.3 -54.1 
0.001 0.52 -12.35 0.06 0.04 1.110 149.57 31.7 -58.9 
0.002 0.54 -12.38 0.07 0.03 1.196 138.80 27.7 -56.6 
1 1.616 102.73 26.0 -54.0 
16-5-16 
0.00025 0.45 -6.31 0.15 0.28 0.887 187.11 42.9 -57.6 
0.0005 0.49 -6.35 0.19 0.21 0.977 169.88 36.9 -56.6 
0.001 0.52 -11.41 0.07 0.04 1.075 154.46 32.2 -58.6 
0.002 0.55 -11.57 0.09 0.03 1.223 135.71 27.9 -55.7 
1 1.405 118.19 29.7 -56.1 
16-6-16 
0.00025 0.43 -5.13 0.19 0.38 0.837 198.30 47.8 -56.7 
0.0005 0.48 -5.88 0.21 0.25 0.943 176.16 41.5 -54.9 
0.001 0.52 -11.03 0.08 0.05 1.107 149.99 33.6 -56.0 
0.002 0.54 -12.04 0.08 0.03 1.156 143.68 33.0 -56.2 
1.236 134.06 33.5 -51.3 
('1.\13 
0.0(102; 	0.58 -2.68 0.63 0.40 1.044 159.10 36.5 -53.1 
0.0005 	0.62 -3.32 0.61 0.28 1.154 143.95 32.2 -51.3 
0.001 	0.63 -4.48 0.54 0.17 1.208 137.41 29.8 -50.9 
0.002 	0.65 -4.68 0.56 0.14 1.463 113.52 21.3 -49.5 
1 2.254 73.65 13.8 -48.9 
14-4-14 
4.00025 	0.41 -10.21 0.03 0.18 0.750 219.60 47.8 -66.6 
0.0005 	0.44 -10.77 0.03 0.13 0.809 205.24 41.5 -69.8 
0.001 	0.46 -9.61 0.06 0.13 0.838 198.22 39.5 -68.5 
0.002 	0.49 -12.30 0.04 0.05 0.832 199.53 39.7 -70.1 
1 1.524 108.93 27.2 -51.1 
96 
0.41 -9.49 0.04 0.20 0.820 202.54 45.2 
0.45 -10.97 0.04 0.11 0.853 194.60 40.4 
0.47 -9.87 0.06 0.11 0.905 183.56 39.9 
0.50 -9.94 0.08 0.08 0.902 183.99 41.0 
1.481 112.15 25.8 
0.42 -9.78 0.04 0.18 0.762 217.93 47.3 
0.45 -10.91 0.04 0.11 0.807 205.64 42.1 
0.47 -8.76 0.09 0.14 0.833 199.21 42.0 
0.50 -9.06 0.11 0.10 0.884 187.92 42.8 
1.439 115.31 25.9 
14-5-14 
0.00025 
0.0005 
0.001 
0.002 
1 
14-6-14 
0.00025  
0.0005 
0.001 
0.002 
1 
TTAB 
0.00025 
0.0005 
0.001 
0.002 
1 
0.42 -4.01 0.26 0.49 1.108 
0.46 -4.31 0.29 0.39 1.236 
0.50 -4.10 0.35 0.36 1.342 
0.52 -4.30 0.37 0.31 1.405 
1.937 
149.80 34.9 
134.32 30.6 
123.75 28.5 
118.13 	16.0 
85.74 37.4 
-64.1 
-66.0 
-62.8 
-64.2 
-55.7 
-66.0 
-67.0 
-64.8 
-60.6 
-56.2 
-44.7 
-44.3 
-43.3 
-51.4 
-44.7 
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Table 3.6: Interfacial composition (X 1, interaction parameter (13 a), activity 
cof'. fUciF'pit,S (t in mixed mono/aver a/UI .surface properties (I r»c~x Anin Gmtn 
and AG,, ) for mixed NOT-cationic surfactant systems. 
Mole 
fraction 
/1 c fr f T'J,u,.' 	10`' 
(mol 012 ) 
A,,,, 
(A2 ) 
G,,,, 
(kJ moI 
AG n 
(kJ mol" ) 
0 1.652 100.52 26.9 -36.6 
16-4-16 
0.00025 0.30 -1.12 0.58 0.90 0.705 235.35 25.6 -59.9 
0.0005 0.43 -2.40 0.46 0.64 0.797 208.23 20.6 -60.1 
0.001 0.50 -6.54 0.20 0.19 0.807 205.66 17.9 -66.5 
0.002 0.54 -6.76 0.25 0.13 0.841 197.44 18.2 -62.9 
1 1.616 102.73 26.2 -54.0 
16-5-16 
0.00025 0.27 -1.41 0.47 0.90 0.730 227.44 24.7 -55.5 
0.0005 0.38 -1.83 0.49 0.77 0.845 196.44 20.9 -52.8 
0.001 0.48 -6.03 0.20 0.24 0.846 196.35 20.4 -56.9 
0.002 0.52 -9.33 0.12 0.08 0.855 194.19 17.4 -66.0 
1 1.405 118.19 30.0 -56.1 
16-5-16 
0.00025 0.26 -1.32 0.49 0.91 	0.584 284.53 82.2 -61.5 
0.0005 0.39 -2.48 0.40 0.68 	0.679 241.46 64.1 -61.3 
0.001 0.48 -6.44 0.18 0.22 	0.795 208.87 51.6 -63.6 
0.002 0.52 -6.54 0.22 0.16 	0.926 197.23 44.8 -56.4 
1 1.236 134.06 33.5 -51.3 
0.0125 0.50 -3.08 0.47 0.47 0.752 220.90 51.9 -63.3 
0.02 0.55 -3.11 0.53 0.39 0.856 193.90 45.0 -60.6 
0.03 0.58 -3.65 0.53 0.29 0.903 183.82 4.1.3 -57.9 
0.04 0.59 -4.58 0.47 0.20 0.912 182.04 42.8 -59.4 
1 2.254 73.65 13.8 -48.9 
14-4-14 
0.00025 	0.36 -7.83 	0.04 	0.37 1).556 298.38 77.3 -71.0 
0.0005 	0.38 -7.13 	0.07 	0.35 0.663 250.47 63.4 -65.3 
0.001 	0.43 -9.20 	0.05 	0.18 0.825 201.22 50.3 -61.4 
0.002 	0.47 -11.02 	0.05 	0.09 0.884 187.75 46.5 -58.8 
1 1.524 108.93 27.2 -51.1 
98 
279.65 65.9 -73.5 
251.31 57.7 -72.3 
247.66 55.9 -72.6 
231.74 51.8 -71.6 
112.13 25.8 -55.7 
301.63 78.3 -72.4 
271.97 67.9 -71.7 
264.61 62.3 -76.6 
187.92 42.8 -62.1 
115.31 25.9 -56.2 
227.62 60.3 -59.8 
195.57 51.3 -55.6 
167.09 42.4 -53.5 
143.38 38.9 -46.3 
85.74 17.1 -44.7 
14-5-14 
0.00025 0.36 -7.83 0.04 0.37 0.594 
0.0005 0.38 -7.13 0.07 0.35 0.661 
0.001 0.43 -9.20 0.05 0.18 0.670 
0.002 0.47 -11.02 0.05 0.09 0.716 
1 1.481 
14-6-14 
0.00025 0.29 -4.45 0.11 0.68 0.550 
0.0005 0.38 -6.09 0.09 0.42 0.610 
0.001 0.44 -9.09 0.06 0.17 0.627 
0.002 0.48 -10.53 0.06 0.09 0.884 
1 1.439 
TTAB 
0.0125 0.38 -4.64 0.17 0.50 0.729 
0.02 0.42 -4.74 0.20 0.43 0.849 
0.03 0.46 -5.58 0.19 0.31 0.994 
0.04 0.47 -4.90 0.26 0.33 1.158 
1 1.937 
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Table 3.7: Interfacial compo.~ition (X 1. interaction parameter (/3'i ), activiti , 
coefficients ({r) in mixed mono/aver and surface properties 	A,»in , Gmi,, 
and 	) Jon mixed CLP-cationic sarrJattarrf systems. 
Mole 
fraction 
xcl fi a JI B J'~ `„nun• 	10 
ono1 M") 
Amrn 
(A2 ) 
G,nm 
(kJ mol') 
AG" 
(k3 mo1"') 
0 1.610 103.11 29.2 -34.5 
16-4-16 
0.00025 0.43 -5.22 0.18 0.39 1.015 163.64 39.5 -52.4 
0.0005 0.47 -4.25 0.30 0.39 1.055 157.37 37.9 -50.3 
0.001 0.52 -11.31 0.07 0.05 1.238 134.06 31.5 -50.1 
0.002 0.54 -11.39 0.09 0.04 1.317 126.07 28.9 -51.8 
1 1.616 102.73 25.9 -54.0 
16-5-16 
0.00025 0.40 -4.69 0.19 0.47 1.027 161.73 40.9 -50.7 
0.0005 0.47 -7.64 0.12 0.19 1.053 157.72 35.2 -55.9 
0.001 0.50 -9.56 0.09 0.09 1.119 148.37 34.9 -54.4 
0.002 0.53 -12.37 0.03 0.03 1.198 138.55 26.7 -60.8 
1 1.405 118.19 29.7 -56.1 
16-5-16 
0.00025 	0.43 -7.57 0.09 0.25 1.083 153.28 34.2 -51.9 
0.0005 	0.45 -4.82 0.23 0.38 1.108 149.90 36.1 -49.9 
0.001 	0.50 -6.74 0.19 0.19 1.161 142.98 33.6 -51.5 
0.002 0.53 -10.42 0.10 0.06 1.284 129.31 24.9 -55.8 
1 1.236 134.06 33.5 -51.3 
0.0125 0.52 -8.82 0.13 0.09 1.203 138.07 30.4 -52.6 
0.02 0.54 -9.58 0.13 0.06 1.211 137.15 29.7 -52.8 
0.03 0.55 -9.84 0.14 0.05 1.540 107.75 22.7 -48.3 
0.04 0.56 -10.97 0.12 0.03 1.560 106.43 22.4 -48.9 
1 2.254 73.65 13.8 -48.9 
14-4-14 
0.00025 0.37 -8.37 0.04 0.32 1.103 150.49 36.8 -49.2 
0.0005 0.40 -7.98 0.06 0.28 1.117 148.62 34.9 -50.5 
0.001 0.46 -12.99 0.02 0.06 1.145 145.00 34.1 -53.5 
0.002 0.49 -13.02 0.03 0.05 1.734 95.73 21.9 -45.6 
1 1.524 108.93 27.2 -51.1 
100 
0.37 -7.48 0.05 0.37 0.885 187.51 48.6 -53.3 
0.40 -7.21 0.08 0.32 0.988 167.98 42.5 -51.3 
0.45 -9.91 0.05 0.13 1.092 152.08 38.0 -51.5 
0.44 -2.48 0.46 0.62 1.151 144.29 35.6 -51.8 
1.481 112.13 25.8 -55.6 
0.37 -7.31 0.06 0.37 0.865 192.02 47.9 -54.8 
0.41 -7.42 0.08 0.29 1.049 158.24 38.1 -51.5 
0.47 -12.43 0.03 0.06 1.149 144.49 33.9 -54.4 
0.49 -12.59 0.04 0.05 1.134 146.46 33.5 -55.7 
1.439 155.31 25.9 -56.2 
TTAB 
0.0125 
0.02 
0.03 
0.04 
1 
0.43 -7.05 0.10 0.27 1.303 127.45 
0.46 -8.37 0.09 0.17 1.399 118.63 
0.49 -9.33 0.09 0.11 1.514 109.68 
0.50 -8.73 0.11 0.11 1.846 89.95 
1.937 85.74 
32.6 -45.0 
29.7 -46.1 
25.8 -45.6 
23.3 -41.1 
17.1 -44.7 
14-5-14 
0.00025 
0.0005 
0.001 
0.002 
14-6-14 
0.00025 
0.0005 
0.001 
0.002 
1 
101 
■ ADP 
A 	 r OT 
• LP 
65- 
55 
t 	 • • 
	
45- 	 % 
40 i 	i 	~-i 	r 	- 	-----  
.4D -35-30 25 :0 	5 	.10 
log C 
70- 	 -  
• • 	F-4.16 
B 	 •6-5.16 
• • '5-6.16 
• TAB 
A 	 • 
• AB 
'4-4-14 
t '45.14 
55- 	• 	 '4 
• 
• 
^ SC 	• • 
45- 	 ■ A 	 • 
S. 
4C - 	 A 	 • 
35 
301 	 . 
5.5 	-50 	-45 	-40 	-35 	-3G 	•25 
log C 
Fig. 3.1: Plots oj'sur/ace tension (yl l'.v log (' olImn.' drugs (.-ii (■ ADP. - A'OT 
rritcl A('[Pi 0/1(1 /)trrc' c•cr(iOitic• .ctn'(urcI 'u1s (13 to 16 - 4- 16, 	16 - 5-16, A /6- 6- 
/6, .A ('TAB. • TT4B. o14-4-14.  * J--5-14 (/i1(l * 1-1 -6-14,. 
102 
70 	
a~~ • ;.a.18 
■ c 
65  
60- 
55 
E S0 
a5  
40 
35-i 	 w• 
30 	—r-- 	 - 	r----~ 
-40 	-3 5 -30 	-25 	.20 	.15 	.1 0 
log C 
70j 	 .. 	?, ~..t6•a.76 
65-{ 	. 	 £''~` 
60 
55 
E 
E Sc 
45 
-4 
	
35 	l 	.. 	2 0 	~ 5 
log C 
70 1 
416 
 
_ 	554 
E 2 	. 
30 
.: 	35 I5 
Fig. 3.2: Plots of stn-face tension ;" vs to<(, (' of 16-4-16 with AL)P (A), NOT 
(B) and ('LP (C) at dt ferrrrt ntulc 1raclirts of 16-4-16 (■ 0.00025, : 0.0005, 
A 0.00/ and .-\ 0. 002). 
1U3 
	A 	~;)P•l5.5 !G 
1 	 • 
0005 
65- 	 4 
6C 
55 
so 
45 
40-i 	 •~ 
,log C 
B 	'JOT 65I6 
■ 
E - 	~. 
45 
JIJII 	 •.... 
40 
sii11 0---- 	•3 5 	3TJ 	25 	.2'0 	1 5 
log C 
70 
C 	5't6 U 	- 
65. 	 KR5 
60  
-
E  
Z 4' _ 
• •rte 
4C 	 •.•.Y. 
35 
30 - 	, -- 	- 	-~—•. 
.40 .35 	i 	25 20 	5 
ogC 
Fig. 3.3: Plots of~surface tensum t/) v lo; (• ?f l6-5-10 with .•il DP /A), ;,'()T 
113) cnu! C'1.P (C') at different mule 11-ac•tioii, of /O-- / O (U (1. 00025, 	0.0005. 
A 0.001 wn/..\ 0.002i. 
104 
5O 
65 
30 
iog C 
70 	 B 	'JT666 
65 
£ 
E 
5- 
70 
C 	•-' 
60 
E 
30 S - - 
.4 5 	.4 0 	3 5 	30 	2 5 	•2 C 	.1 5 
log C 
Fig. 3.4: Plots ofsurtaee  tension (7) vs log C of 16-6-16 with .4DP TA,. ,S1JT 
R cnui (LI' (C) at different  ,iiole .tracliaiis  o/10-6-16 (• 0. 0002.5, 	0.0005, 
A 0.00] and L\ 0. 002). 
105 
I 	 A:P.CrAS 
f • 	7 ~25 
65 I 
60- 
55 
E 
45 
Z 50 
40  
35 
fog C 
70  
65 	
47 	• 
45 
40 	 •i 
35 ~ 	 •••N • 
•4 0 	•3.5 	-3 0 	•25 	-2 0 	-IS 
log C 
7C 
~ 	 8 
65 ' 	 A 
aS 
10 
35 Jj_~ 
log C 
Fig. 3.5: Plots uf•su face tension t/i vs 1o, ( of ('T-IB it'ith ADP (A), NOT (B/ 
and (LP (C) at different mole . fractions of C'TAB t■ 0. 01 5, c 0.02. A 0.03 
and A 0.04, . 
106 
::
1 
	 ---- 
54 
50  
F 
	
-
E a5 	 , 
4C 
35 
30 -x— •— 	--. -40 	.36 	32 	-=8 
log C 
• NM4 
6 	' .a, 
60 
E 	55 
50 
45 	I ••• 
..r 
dC 
~•W 
Jong C 
70 
• _t 
65 . 	 4 
60 I 	- 
1 • 
E 
4t 
4 
.40 	.4 J 	_  
log C 
Fig. 3.6: Plots of surface tension i';' vs log, ( of I4-4-14 with ADP (A), NOT 
(B) viii / CLP (C) at cliff scar 1110l~• !ract Ortv of 14-4-1- ( 0. 00025, IT 0.0005, 
A I). 001 and \ 0. 002). 
107 
70 
65 
60 
55 
45 
4C 
35- 
0 4 4 
• --.: 
£ 
log C 
50 
45- 
40 
35 
-4 - 	 20 	 5 
tog C 
73 	 - 
CLP.l4-5-4 
C U 	•IUHI 
a - 	..... 
60 -. 
Sc 
-45 	.4)  
log C 
Fig. 3.7: Plots of suP/c/ce tens/oil (y, vs log C 01'14-5-14 it'ith -IDP (A), NOT 
(B) and CLP (() at different mole fractious of 14-)- 14 (U (1. (10025, 	0. 0005, 
A 0.001 andA 0.002). 
W. 
70 
A P'14-6.14 
• =0 00025 
:=O 0005 
h: 	
• 	 =0 001 
• :=0 002 
• 
50 
■ 
401 
.4U 	-?S 	-  
log C 
70 NOT14.g; 11 4 , 
B 
65 
5.` 
45  
4D 
IC 	, : 5 	-20 	t~5 
jog C 
7C 
C 	~CLP04.6-14 
• u0uu~$ 
60 
55- 	 . 
50 
45 	 .. w 
35 	
r.4 5 	.40 	-3 5 	.3j 	.35 	-20 	-IS 
jog C 
Fig. 3.8: Plots of surface tension (7l t•.s !''g (- of 14-h- '-t with ADP (A), NOT 
(131 and ('LP (C) at different mole tractions of - 14-6-1.1 %■ 0.00025, ❑ 0.0005. 
A /1.001 and :\ 0.002. 
109 
AIP TTAB 
:. 	.t 5 	70 
tog C 
c I 	 g  
z ss~ 	• 
♦ so .~ 
4a 
.a0•35 	.c 	.25 	•20 	•15 
log C 
C 	P7'. TAAB 
• 
1 	' 
40 -.-- 	 0 
log C 
Fig. 3.9: Plots 0/surface tension (, t vs log, ( of 7'TaB with ADP (A), NOT (B) 
and ('LP (C't (it differe#ii m ole .lr(Icti011' of TT-413 (■ 1).01 5, c 0.02, A 0.03 
and c 0.04). 
It 
A 
E 
E 
o + 00 1 
C 65 	 • t64-•5 
o 16.5.16 
0 80 	 ~16.6-16_. 
3004 	D CC 5 	_.- 2 	0 3016 	0 0020 
vote f'8c0.'l 137 s 'factants 
B 
0 90 
E C 
t 	~ 
of-.. 	 • 	c 4 ,6 
_- 	 6.5.16 
L. • 16-6-16 
ft 	:; 0020 
Mole L 3c!,on of surfactants 
- .1 
~E 	I 
0 0 7C 
COO 
Mcte fraction of surfactants 
4~ig. 3.10: 1 arrulio;1 of l,,,,,, with ittolc' ti'(rc•tiurr c,t t rfcictwitn Joi -~01' (A), NOT 
A and ('LP (C) (M 6-4-16, - 16-5-10 (rlK! A 16-6-16i. 
IS 
14 
,- t 3 
i 
0 
MGr !+J C`o^ of s , r!acfan fS 
I' 
B 	• `" B 
12 
E 	 i 
0 
o - . 
:0 	i C'S 	)Coo 	UC25  
Mole fraction of surfactants 
C 
08  
08C 
of 075 
t 	1 
0 70 1 
065 
0 6C 
)- - 	- ' 	_ 	 3330 	'0035 	0040 
MOre f+ac5On of surfactants 
Fig. 3.1 1: I- ariatioit o11„ with mvlc, fraction oJ'stiu~l~rrtunts /or ADP (A), NOT 
(1) and CLP (C) (■ (T-1B and c TT B). 
112 
Mole fraction of surfactants 
o y. 	• '44'4 
 w 5 13 
'i 
39_ 
E ar5 
0 70 
065 
063 
o5 1 t 
	
. .. t 	00008 	0 0012 	00016 	0 0020 
Mote fraction of surfactants 
05` 
E 
C 
O SSj 
• I 5 	• dq .4 1 
45 t4 j 
051 ~-  --- 	--- 	--- 	
A '4.13.14 
C] 004 	3 C :1 d 	_ ;, - 1. 	0 0 715 	00020 
Mote fraction of surfactants 
080 .r" aE 
083 
Fig. 3.12: ['(u•iation of l T,, with mole fYc,C1lUl7 of sur(ackm !s for ADP (A), NOT 
iR) and (LP ((v) (■ 1-1-4-1-1.:' 14-5-141ri'tl A 14-0-1-1). 
200 	 --  
• 04.'6 
'DC 
, 7C .. 
+6C -. 
ISO 
130 	-.. - 	-- 	.- 00004 000oe 000+2 0  301b 
Mole fraction of surfactants 
290 
B 	~~ +60.16 2D0 	 A t66 t6 , 
270 .  
260 
250 - 
24I - 
230 
220 - 
21C 
200 
I 	 ~ 
Mole fraction of surfactants 
26: 
'0240, 
22C - 
Mole fracnen of satractants 
Fir;. 3.13: I w iatioir of'A,, with mole Ti•eimrt,li oj'surfactants for ADP (A), NOT 
i[3 wul ('LP ((') I■ I6-4-16, -i 16-5-I6 tr;nl A 16-6-16). 
ME 
A •  
0 010 	C 010 	0 029 	. ':2: 	. 030 	0 035 	0 040 
Mote fraction of surfactants 
260 B 	 • TB 
a TTAB 
240 
220 
200 
!60 
40 
0 0004 	O 0006 	CC '2 	C 0016 	00020 
Mole traction of  surfactants 
2e0 
■ CTAB 
• C ❑ TTAB 
26C 
240 \' 
220 
200 a 
180 
00?0 	0015 	0020 	0025 	0030 0035 	0040 
Mole fraction of surfactants 
Fig. 3.14: 1'wlatioiz of'A„t ,,, 11/1/i /110/C frucli0/7 of Surfactants for ADP (A), NOT 
(13i and ('LP (ii. (TAB and TT-1B). 
230 A • 
4-G.,4 
'45.14 
220 
2,0 .1 
	
a ~ 	• 
Q20: 
190 
0 0004 	00008 	0 JC f2 	00016 	0 9020 
Mole traction of surfactants 
. 14.4.14 
003 	 r. 	, 4.5.14 
1 46 '4 
2b: 
26C 
Q~ 
240 
22C 
200 
I82 - 
00004 	07VU8 	7032 	0 i0l6  
Mole traction of surfactants 
• ; 1 74 
I : 	,4..14 
•,4.10 f4_. 
300 	k 
290 
280 
273 
260 
25' 
24. 
Mole fraction of su'tactants 
Fig. 3.15: 1 'an ration 0J'Atn,,, ivith rno1C .11-act ml of surfaclaints for ADP (A), NOT 
(Li) wicl ('Li' (C) t ■ 14-4-14. 	14-5-14 a to i ♦ 14-6-14). 
i~ 
(II) Studies with Anionic Surfactants 
Anionic surfactants are amphipathic compounds consisting of a 
hydrophobic and a hydrophilic part. Anionic surfactants not only change the 
surface characteristics of solids by adsorption but can also enhance the solubility 
of sparingly soluble compounds in tt atcr [28]. Due to their favorable 
physicochemical characteristics, anionic surfactants are extensively used in many 
fields of technology and research. Anionic surfactants have been successfully 
employed for the enhancement of the efficacy of the active ingredient in 
pharmaceutical [29] and agricultural formulations [30], in hiotechnological [31] 
and in other industrial processes [32]. 
Bile salts behave like anionic surfactants [331; however, the formation of 
bile salt micelles differs from that of the surfactants. These surfactant 
characteristics result from the combination of the polar hydroxyl groups on the 
concave a-face and the methyl groups on the convex p-face [34.35]. Bile salts in 
aqueous solution form aggregates mainly clue to hydrophobic attractive 
interactions of the polar n-faces [36]. However, further .stabilization and 
aggregation occurs through intermolecular hydrogen bonds formation [37,38]. 
These antphipathic compounds are present in bile as mixed micelles that serve to 
transport additional cholesterol from the liver into the intestine [39,40] '[he 
physiological and therapeutic properties of some bile salts [41] are essentially due 
to their ability to form both simple and mixed micellnr aggregates, which facilitate 
the dissolution and transportation of lipo-soluble molecules. Mixed micelles of 
bile salts are promising systems for drug delivery [42]. It has been observed that 
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the bile salts form mixed micelles with the dru;12s ]43 ]. Bile salts are known as 
.permeability enhancers to increase drug penetration through various biological 
membranes by interacting with phospholipids in cell membranes [44,45]. Micelles 
of bile salts have been investigated in different pharmaceutical formulations where 
they solubilize poorly soluble drugs [46-49). The ability of bile salts to achieve 
this is mainly dependent on their hydrophobicity. Bile salts with more 
hydrophobic micellar core have greater 	ability to accept hydrophobic 
pharmaceutical ingredients [47J. 
Results and Discussion 
\Whereas the cnzc s of pure bile salts. Table 3.8 and Fig. 3.16 are in good 
agreement with literature [50-52]. the experimental cmc values of the mixture of 
the systems (Table 3.8 and Figs. 3.17 to 3. 19). show a decrease with increasing 
concentration of bile salts. the values of cnic are dc \ iating from the predicted 
ideal behavior, which indicates synergism in mixed micelle formation. The 
deviation of cmc values of binary hi le salt-drug mixtures from those calculated 
according to Clint's theory [10]. equation (I.1), indicates nonideal behavior of the 
examined mixtures and the existence of' mutual interactions of' the components in 
the micelles. 
Both .V and .V values increase with increase of bile salt concentrations. 
As shu\\ n in fables 3.9 to >.1 1. the \ alues o1' 1 " are smaller than .1 ' but are 
greater than cf As the concentration of bile salts increase, their contribution in 
mixed micelles also increases. X, values are higher than a, indicating that some 
of the drug molecules are replaced by the bile salts in mixed micelles. x;' being 
greater than X;° indicates that the micelles rich in bile salts as compared to the 
mixed micelles at ideal mixing. 
The more negative value of /3"t  interaction parameter indicates stronger 
synergism between the components. From the results (Tables 3.9 to 3.11), it can 
be observed that the values of fY" are negative at all molar ratios of the mixture. 
These values correspond to the deviation between experimentally obtained cmc 
and the calculated emc* values and indicate synergism in all investigated bile salt-
drug mixtures. The order of hydrophbicity of three bile salts is: NaC < NaTC < 
NaDC. In spite the NaDC being more hydrophobic than NaC, NaC creates 
stronger interactions with the investigated drugs. The stronger synergistic effect of 
NaC compared to NaDC can be explained by the fact that NaC contains tow a-
axial hydroxyl groups at C7 and C12 positions, while NaDC has only one ix-axial 
hydroxyl group at C12. Obviously, the number of a-axial hydroxyl groups is 
important for the stability of the micelles [53]. 
The values of activity coefficients j;" and f, (Tables 3.9 to 3.11), 
calculated from equations (3.5) and (3.6), are found to be less than unity showing 
nonideal behavior of the mixed systems. 
The negative AC a values (Tables 3.9 to 3.11) suggest that the mixed 
micelles are stable than micelles in individual components. 
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AG ° (the standard Gibbs energy of micellization of the pure and the mixed 
system) were calculated using equation (3.8). All the values of AGO are negative 
indicating that the process of micelle formation is spontaneous. The magnitude of 
AG ,° increase with increase of bile salts concentration in mixed systems, which 
means the presence of negatively charged bile salts reduces the electrostatic 
repulsion and makes the process more spontaneous. 
The X, values, calculated by using equation (3,10) and given in Tables 
3.12 to 3.14, were found to be lower than x, values, suggesting that less 
surfactant is present in mixed monolayer as in mixed micelles. 
The %° trend, (Tables 3.12 to 3.14), is similar to fl i.e_ the mixtures of 
bile salts/drugs show stronger attractive interaction at the solution/air interface. 
The O'values are more negative than the fi' which imply that the interaction at 
the solution/air interface is stronger than the mixed micelles; this is due to the 
steric factor which is more important in micelle formation than in monolayer 
formation at a planar interface. Increased bulkiness in the hydrophobic group 
causes greater difficulty for incorporation into the curved mixed micelles 
compared to that of accommodating at the planar interface. The values of activity 
coefficients, j° and f, , (Tables 3.12 to 3.14), are found to be less than unity 
showing nonideal behavior. 
The values of "ma.  and d,,,, , calculated by equations (3.13) and (3.14), are 
given in Tables 3.12 to 3.14 (see also Figs. 3.20 and 3.21) . A value ofn = 3 was 
120 
used for mixtures, whereas for pure bile salts n = 2 was employed. I'ntar increases 
with increase in the additives (bile salts) concentrations, this indicates that the 
drug solutions in presence of bile salts have greater preference to be adsorbed at 
air /water interface, compared to the pure drug solutions. The A,„;,, values decrease 
with increasing additive concentrations (Tables 3.12 to 3.14); this is due to 
progressive charge shielding and closer packing of drug ions in the surface. 
The Gmin , listed in Tables 3.12 to 3.14, are found to decrease with increasing 
additive (bile salts) mole fraction. The lower values of Gmjn indicate that the more 
thermodynamically stable surface is formed. 
All .\G~dS values are negative (Tables 3.12 to 3.14) which imply that the 
adsorption of amphiphiles at the air /mixture interface takes place spontaneously. 
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Table 3.8: triation of c'ntc caul cmc -' for ini.ved c!i•1r,-bile sail systems. 
Mole fraction ADP NOT CLP 
C!11(..' t'l11C `  (Tfl( C'11/C C11/C C/)IC *  
(mM) (mlvi) (11M) (mM) (mM) (mM) 
U 41.0 2U.8 18.48 
NaC 
0.0025 10.06 40.6; 10.54 20.73 8.60 18.43 
0.003 % 8.56 40.-16 7.79 20.7O 8.30 18.41 
0.005 7.21 40.28 6.84 20.66 6.75 18.38 
0.0062 4.94 40.II 4.96 20.63 5.07 18.36 
1 8.92 
NaI)C 
0.0025 7.30 38.94 12.81 20.28 11.58 18.07 
0.0037 5.36 38.0') 9.01 20.0 7.65 17.89 
0.005 4.35 37.08 8.04 19.79 6.61 17.69 
0.(1062 3.41 36.25 6.59 19.56 3.88 17.50 
1.85 1 
NaT( 
0.0025 17.83 40.34 12.59 20.65 10.47 18.37 
0.0037 16.12 40.02 9.46 20.58 7.91 18.32 
0.005 14.06 38.70 5.60 20.51 6.83 18 2..6 
0.0062 10.63 39.40 3.19 20.44 4.61 1 K.? 1 
1 5.42 
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Table 3.9: [Various physicochemical parameters (i.e., X,' 	XI'" ,/1 „1 Jt », f,PJ ; ) 
and AG,',) for mixed ADP-bile salt systems. 
Mole  -- 13 `I ni f'm AG AG" 
fraction 1  l (kJ mol ) (kJ mol- ' 
0 -18.2 
NaC 
0.0025 0.32 0.01 -10.15 0.009 0.359 -5.5 -21.7 
0.0037 0.34 0.02 -l0.3()  0.01 1 0.313 -5.8 -22.1 
0.005 0.35 0.02 -10.61 0.012 0.270 -6.1 -22.5 
0.0062 0.37 0.03 -11.92 0.009 0.191 -7.0 -23.5 
I -22.0 
NaDC 
0.0025 0.37 0.05 -9.20 0.027 0.280 -5.4 -j2.5 
0.0037 0.39 0.08 -9.85 0.027 0.215 -5.9 -23.3 
0.005 0.41 0.10 -10.22 0.029 0.179 -6.2 -23.6 
0.0062 0.42 0.12 -10.86 0.027 0.143 -6.9 -24.4 
1 -25.7 
NaTC 
0.0025 0.28 0.02 -6.71 0.30 0.599 -3.4 -20.3 
0.0037 0.30 0.03 -6.66 0.037 0.559 -3.5 -20.5 
0.005 0.31 0.04 -6.87 0.041 0.500 -3.8 -20.9 
0.0062 0.35 0.04 -7.81 0.035 0.394 -4.5 -21.6 
1 -23.3 
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Table 3.10: Various physicochemical parameters (i.e., X, X;d , fln fj"', f2"', AGO 
and AG').for mixed NOT-bile salt systems. 
Mole X ^' I X;° I 
rn ~'"' 
/1 m ~2 G° ex AG° m 
fraction (kJ mold ) (kJ mold) 
0 -19.9 
NaC 
0.0025 0.24 0.006 -7.50 0.013 0.66 -3.4 -21.6 
0.0037 0.28 0.009 -8.60 0.012 0.51 -4.4 -22.4 
0.005 0.30 0.012 -8.89 0.013 0.45 -4.7 -22.7 
0.0062 0.33 0.014 -10.16 0.010 0.33 -5.7 -23.5 
1 -22.0 
NaDC 
0.0025 0.23 0.027 -4.36 0.075 0.79 -1.9 -51.1 
0.0037 0.30 0.040 -5.74 0.060 0.59 -3.0 -51.3 
0.005 0.32 0.053 -5.82 0.068 0.55 -3.2 -46.3 
0.0062 0.35 0.066 -6.41 0.064 0.47 -3.7 -51.4 
1 -25.7 
NaTC 
0.0025 0.22 0.010 -5.97 0.026 0.75 -2.6 -21.1 
0.0037 0.28 0.014 -7.14 0.023 0.58 -3.6 -21.9 
0.005 0.33 0.019 -9.26 0.016 0.37 -5.2 -23.2 
0.0062 0.38 0.023 -11.63 0.010 0.20 -6.8 -24.6 
1 -23.3 
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Table 3.11: Various physicochemical parameters (i.e., X, X;d ,,X, f1m f7", AG° 
and AGm )for mixed CLP-bile salt systems. 
Mole 
fraction 
X m 1 X`° I Y JI /~m J2 tr 
(kJ mol"I ) 
m 
(kJ mol-1) 
0 -20.2 
NaC 
0.0025 0.25 0.006 -8.10 0.010 0.164 -3.78 -20.7 
0.0037 0.27 0.008 -7.78 0.013 0.600 -3.73 -21.2 
0.005 0.29 0.010 -8.45 0.013 0.503 -4.34 -21.9 
0.0062 0.32 0.013 -9.75 0.011 0.369 -5.34 -22.4 
1 -22.0 
NaDC 
0.0025 0.22 0.024 -4.40 0.070 0.803 -1.92 -23.3 
0.0037 0.30 0.036 -6.07 0.051 0.579 -3.21 -24.6 
0.005 0.32 0.048 -6.29 0.055 0.521 -3.46 -25.1 
0.0062 
1 
0.30 0.059 -6.41 0.043 0.562 -3.39 -25.7 
NaTC 
0.0025 0.23 0.009 -6.52 0.021 0.71 -2.91 -23.0 
0.0037 0.28 0.012 -7.62 0.019 0.55 -3.87 -23.9 
0.005 0.30 0.017 -7.97 0.021 0.48 -4.24 -24.1 
0.0062 0.34 0.028 -9.50 0.016 0.33 -5.40 -26.0 
1 -23.3 
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Table 3.12: Interfacial composition (.V i. ilueraction parameter (fi °), activity 
coefficients 'I in mired mono/aver and surface properties (I'im~r • Aurrrr G,,,,,, and 
AC`,,) jdr mixed ADP-bile salt swtems. 
Mole 1'° 	 f,R 	f" 	r,,:,..10`' 41,11,  ,r,,„  
fraction (mol m) (.\-') (kJ mol ') (kJ mol - ' ) 
0 1.734 95.76 24.8 -34.6 
NaC 
0.0025 0.389 426.92 129.7 -77.1 
0.0037 0.411 404.44 131.5 -63.5 
0.005 0.467 355.26 112.E -62.9 
0.0062 0.579 286.67 90.0 -57.8 
1 0.973 170.68 50.3 -45.1 
Na l)(' 
0.0025 0.391 424.59 127.9 -76.2 
0.0037 0.30 	-6.28 	0.09 	0.56 	0.440 377.33 111.4 -71.0 
0.005 0.29 	-4.85 	0.01 	0.68 	(1443 374.32 111.1 -74.9 
0.01)62 O. 38 	10.1)2 	0.72 	0.23 	1-178 347.21 97.2 -78.8 
1 0.903 183.95 53.5 -51.9 
NaTC 
0.0025 0.648 256.39 75.7 -55.5 
0.0037 0.24 	-6.81 	0.01 	0.68 	0.728 228.04 63.4 -55.9 
0.005 0.30 	-9.01 	0.01 	0.44 	0.731 227.27 58.9 -60.8 
0.01)62 (1.31 	-8.92 	0.49 	0.42 	(3.828 204.42 54.3 -54.2 
] ).799 207.55 61.2 -52.0 
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Table 3.13: Intert tcial c'ompositio►n I X," ). interaction parameter (fi °/, act/v/tY 
coefficient (/) in mixed monoiaY r and surface properties (Tin ,, Amrn 1 Gm,,, and 
J Jon- mixed NOT bile salt systenrs. 
Mole 
fracton 
X~° 13R A ll .f2° Tnj\.10 
(mol rn') (A) 
A 
(kJ mol') (kJ mol- ') 
0 1.652 100.52 26.9 -36.5 
Nac 
0.0025 0.857 193.85 48.6 -57.0 
0.0037 0.877 189.28 55.9 -47.4 
0.005 0.21 -6.81 0.014 0.74 0.957 173.42 51.2 -46.1 
0.0062 0.24 -6.87 0.413 0.71 0.979 169.56 47.1 -50.4 
1 0.973 170.68 50.4 -45.1 
Nano 
0.0025 0.26 -6.74 0.002 0.64 0.933 177.93 46.1 -51.1 
0.0037 0.39 -15.79 0.166 0.09 0.9.11 176.42 46.8 -51.3 
0.005 0.25 -4.86 0.032 0.75 0.998 166.06 47.0 -46.3 
0.0062 0.38 -11.72 0.880 0.18 1.134 146.40 34.8 -51.4 
1 0.903 183.95 53.8 -51.9 
N aTC 
0.0025 0.713 232.99 70.2 -52.0 
0.0037 0.736 225.60 67.9 -52.4 
0.005 0.19 -5.57 (1.83 0.742 323.67 66.0 -53.8 
0.0062 0.762 317.82 64.3 -54.5 
1 0.799 207.55 61.5 -52.0 
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Table 3.14: Inte,facial composition 	interaction parameter (13 °), activity 
eoG'JfIeiC'nls Mf r ) in mired mono/aver and surface properties (rxrrnx, A,nan Gmrn and 
A(J;,) for mixed CLP-bile salt systems. 
Mole i~  ' /j o {~ o f / / T / 2 b rd~ . 1 0 Amm min d~lud 
fraction 1 	 1t 	1 	111 	= (A') (kJmol 	) (kJmol 	) 
0  1.610 103.11 24.8 -34.5 
NaC 
0.0025 0.34 -15.63 0.47 0.16 0.665 294.87 61.7 -65.7 
0.0037 0.35 -15.31 0.47 0.15 0.714 232.55 56.7 -64.9 
0.005 0.36 -14.97 0.40 0.15 0.779 213.31 53.3 -61.2 
0.0062 0.37 -16.35 0.29 0.11 0.809 205.26 51.3 -60.7 
1 0.973 170.68 50.7 -45.1 
NaDC 
0.0025 0.33 -9.38 0.58 0.37 0.674 246.53 63.8 -64.4 
0.0037 0.35 -10.02 0.45 0.29 0.824 201.51 51.6 -58.8 
0.005 0.34 -12.40 0.31 0.14 0.833 199.43 49.8 -60.1 
0.0062 0.42 -17.65 0.51 0.04 
1 
0.862 192.65 42.9 -65.8 
0.903 183.95 53.5 -51.9 
NaTC 
0.0025 0.27 -9.57 0.56 0.50 0.661 251.17 67.3 -61.6 
0.0037 0.32 -11.61 0.55 0.30 0.672 246.98 65.4 -63.1 
0.0u5 0.34 -12.36 0.42 0.24 0.1] 233.51 61.2 -62.3 
0.0062 X1.3 7 -1 5.1)3 0.54 0.13 0.715 232.1  1 60.1 -64.0 
1 0.799 207.55 61.5 -52.0 
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(III) Studies wit/i Nonionic Surfactants 
Nonionic surfactants. due to their favorable physicochemical properties, 
are used in pharmaceuticals to increase their stability [54] and to enhance the 
dissolution rate of active ingredients from suppositories [55] and solid 
dispersions [56]. These surfactants are also used to facilitate solubilization [57] 
and to increase the stability of drug carrier emulsions [58]. Some of the 
surfactants used in pharmaceutical formulations are Cremophor EL [59], Tween 
80 [60], Triton X-100 [61], Poloxamers [62], Brij 54 [63], Cremophor RX-40 
[64], Cetrimide [63], etc. 
Triblock copolymers of the type poly (ethylene oxide) — poly (propylene 
oxide)- poly(ethylene oxide) (PEO-PPO-PEO) are members from nonionic 
surfactants. They have found widespread industrial and commercial applications 
as emulsifying, wetting, thickening, coating, solubilizing, stabilizing dispersing, 
lubricating and foaming agents [65]. Amphiphilic block copolymers have proven 
to he one of the most promising families for use in micellar drug formulation and 
delivery. They are highly versatile materials as they may be synthesized to suit 
specific applications. In aqueous media, the amphiphilic copolymers self-
assemble to form nano-sized micelles that include a hydrophobic core 
surrounded by hydrophilic corona. The hydrophobic core of micelles may be 
used for solubilization of hydrophobic drugs. In few cases block copolymer 
micelles have been proven to function as true carriers meaning that have been 
shown to be capable of retaining the drug until reaching the target/desired site 
[66]. 
135 
Results and Discussion 
The crnc values for pure surfactants agree well with the literature values 
[67] and the values of cmc of the mixed systems, given in Table 3.15 (see also 
Figs. 3.22 to 3.26), show that the cme values decrease with the increase in 
stoichiometric mole fraction of nonionic surfactants (a,). The values fall in 
between those of the pure components. This means that the two components 
form mixed micelles. At a, — 0.0015 of Tween 40, the one value for the ADP-
surfactant system shows a sharp decrease from 41.0 to 8.86 mM. For a, higher 
than 0.0015, although cmc values decrease, the rate is slower, i.e., from 8.86 to 
2.8 mM when a, changes from 0.0015 to 0.006. Similar is the trend with other 
surfactants as well as with NOT-surfactant and CLP-surfactant systems. The 
presence of nonionic surfactants in between the positively charged heads of drug 
monomers reduces the inter head group repulsions and makes micellization 
easier. 
We get that the ideal cmc values cmc* are always greater than the 
experimentally determined cmc values. The negative deviation from ideality 
indicates attractive interactions between the two components forming the mixed 
micelles. Reduction in repulsions among head groups, ion-dipole interactions 
among cationic—nonionic head groups, and hydrophobic interactions lead to 
negative deviation of the system from ideality. 
Micelle mole fraction (X;') values, calculated according to equation (3.2), 
are given in Tables 3.16 to 3.18. These values (except for a, = 0.006 for Tween 
40, Tween 80, P85 with ADP and Tween 40 with NOT) increase continuously 
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with a,. Except in NOT— P85 systems, X;" values vary from 0.5-0.81 in other 
systems. This indicates that the behavior of drug—surfactant mixed system is 
basically ruled by the strong tendency of nonionic surfactants to micellize. 
Tween 80 is more hydrophobic than Tween 40 and hence its contribution is more 
in mixed micelles than that of Tween 40. Similar is the case of P85 and F 108. 
The mole fraction of surfactant in ideal mixed state (X;° ) has been computed 
using equation (3.4). The values are greater thanX,'", Tables 3.16 to 3.18, which 
indicate that the micelles are rich in drug. 
The J3"values for all the systems (Tables 3.16 to 3.18) are negative 
suggesting that the attractive interaction between the drugs and nonionic 
surfactants is stronger than the individual components. The values of f l"' and f2' 
(Tables 3.16 to 3.18) are all less than unity, again confirming the non ideality in 
the mixed systems. 
The stability of mixed micelles is confirmed by the negative value of 
excess free energy of mixing AG x (Tables 3.16 to 3.18). All the negative AGO 
values show that the drug-surfactant mixed micelles are more stable than the 
micelles of pure drugs. 
Also all AG,' are negative indicating that the process of micelle formation 
is spontaneous. For mixed systems, the magnitude of 1G, increases with the 
increase in a 1 . This is understandable as presence of surfactants in between the 
head groups of drugs reduces the electrostatic repulsion and makes the process 
more spontaneous. 
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The equation (3.10) used to calculate mole fraction of' surfactants in 
mixed monolayer was non convergent for ADP- surfactant systems and also for 
some systems of NOT and CLP. Non convergence has been reported for other 
systems also [68-701. 
l" values are always greater than X;', \ glues ("fables 3.19 to 3.21). This 
means the participation of surfactants is more in monolayer formation than in 
micelle formation. The hydrophobicity of drug makes micelle formation more 
favorable with drugs and hence they participate more in micelle formation. 
The values of interaction parameter. 13' (Tables 3.19 to3.21). are negative 
except for NOT—P85 systems. The negative values indicate strong attractive 
interactions. 'l'he magnitudes of fl( 	<zrcater than /3"' values. The data are 
insufficient to dray% any conclusion re`ardiii nature of mixed monolayers. The 
values of j" , 7 (Tables 3.19 to 3.21). are less than unity, indicating nonideal 
behavior in the mixed monolayer. 
the [,. , and J,,,, '. aloes are calculated by equations (3. 13) and (3. 14) 
with n - 1 for nonionic surfactants, it = 2 for pure drugs and it = 3 for mixtures. 
The values arc given in fables 3.19 to 3.21 (see Figs. 3.27 to 3.28). At a, = 
0.0015. the [', ,, values in all sN steams sho\\ a sharp decrease. For greater a 1 , 
values increase slightly with increase in v. i Nla\ be. at first addition, nonionic 
surfactant disturbs the surface and I;,,(,,. decreases sharply. Also, with the addition 
of' nonionic surfactants. drus trail inked iii ccl Jes with the surfactants and the 
monola'. er will be loose. Similar trend Of decrease and then increase was 
observed by Oida et al. 171  also. Values oi'.4,., ,. follow opposite order. 
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The values of G,,,,,, , calculated by equation (3.15) and listed in Tables 3.19 
to 3.2 1, are found to decrease with increasing additive (nonionic surfactants) 
mole fraction. The lower the value of G,„;n , the more thermodynamically stable 
surface is formed. 
The z G values are negative and are lower than OG„ . The absolute 
values are more than double (and in some cases even greater) of AGm , indicating 
that the hydrophobicity of the components leads them towards the interface. 
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Table 3.15: Variation of cmc and cmc* for mired drug-nonionic surfactant 
systems. 
Mole ADP NOT CLP 
fraction cmc cmc* cmc cmc* cmc cmc* 
(mM) (mM) (mM) (mM) (mM) (mM) 
0 41.0 20.8 18.48 
T40 
0.0015 8.86 12.71 4.39 9.77 3.69 9.20 
0.003 5.94 7.52 3.16 6.39 2.00 6.15 
0.0045 4.73 5.34 2.40 4.74 1.92 4.61 
0.006 2.80 4.14 1.32 3.77 0.54 3.69 
1 0.028 
T80 
0.0015 5.45 7.25 2.69 6.19 2.14 5.96 
0.003 3.29 3.98 1.78 3.63 1.99 3.56 
0.0045 2.24 2.74 1.08 2.57 1.56 2.53 
0.006 1.54 2.09 0.92 1.99 0.83 1.97 
I 0.013 
P85 
0.0015 15.12 19.16 6.97 13.19 5.17 12.22 
0.003 10.8 9.27 4.73 7.61 4.56 7.27 
0.0045 7.41 9.28 2.96 7.61 2.52 7.28 
0.006 4.78 7.38 1.38 6.29 2.19 6.06 
1 0.05 
Fl 08 
0.0015 6.11 14.69 3.22 10.90 3.25 10.23 
0.003 3.86 8.95 2.47 7.39 2.62 7.07 
0.0045 3.16 6.43 1.66 5.59 1.59 5.40 
0.006 2.89 5.02 0.86 4.49 0.83 4.37 
1 0.034 
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Table 3.16: Various physicochemical parameters (i.e., Xi", X;',/f", f'", fl'", AGa 
and AG) for mixed ADP-nonionic surfactant systems. 
Mole X."` X;' /3 1. J~ AGu AGm 
fraction (Id mol-1) (kJ mol"') 
0 -18.2 
T40 
0.0015 0.61 0.69 -1.58 0.79 0.55 -0.9 -22.0 
0.003 0.72 0.87 -1.31 0.90 0.51 -0.7 -23.0 
0.0045 0.79 0.87 -0.88 0.97 0.57 -0.4 -23.6 
0.006 0.73 0.89 -2.56 0.89 0.25 -1.3 -24.9 
1 -36.6 
T80 
0.0015 0.71 0.82 -1.57 0.87 0.45 -0.8 -23.2 
0.003 0.79 0.90 -1.49 0.94 0.39 -0.6 -24.5 
0.0045 0.81 0.93 -1.86 0.94 0.29 -0.7 -25.5 
0.006 0.79 0.95 -2.76 0.89 0.18 -1.2 -26.4 
1 -38.4 
P85 
0.0015 0.52 0.53 -0.95 0.81 0.77 -0.6 -20.7 
0.003 0.65 0.69 -0.67 0.92 0.75 -0.4 -21.5 
0.0045 0.69 0.77 -1.14 0.90 0.58 -0.6 -22.5 
0.006 0.68 0,82 -2.26 0.79 0.36 -1.2 -23.6 
1 -34.9 
F108 
0.0015 0.55 0.64 -3.62 0.48 0.33 -2.3 -23.0 
0.003 0.61 0.78 -3.85 0.55 0.24 -2.3 -24.1 
0.0045 0.65 0.84 -3.62 0.64 0.22 -2.1 -24.6 
0.006 0.69 0.87 -3.16 0.74 0.22 -1.7 -24.8 
1 -36.0 
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Table 3.17: Various physicochemical par 	 ,I' ameters (i.e., X X'd f3" y; p OG' 
and 4G;.) for mixed NOT-nonionic surfactant systems. 
Mole 
fraction 
X,°' X;° /3°' jm jz aGu 
(kJ mol") 
AGE 
(k7 mot ) ) 
o -19.9 
T40 
0.0015 0.512 0.531 -3.21 0.53 0.43 -2.0 -23.8 
0.003 0.580 0.694 -3.09 0.63 0.35 -1.9 -24.7 
0.0045 0.619 0.773 -3.16 0.57 0.30 -1.9 -25.3 
0.006 0.609 0.820 -4.90 0.62 0.16 -2.9 -26.8 
1 -36.6 
T80 
0.0015 0.578 0.703 -3.58 0.47 0.30 -2.2 -25.0 
0.003 0.639 0.826 -3.53 0.58 0.24 -2.0 -26.1 
0.0045 0.649 0.877 -4.59 0.63 0.14 -2.6 -27.3 
0.006 0.673 0.905 -4.45 0.47 0.13 -2.5 -27.7 
1 -38.4 
P85 
0.0015 0.443 0.367 -2.74 0.43 0.59 -1.7 -22.6 
0.003 0.388 0.537 -2.86 0.51 0.47 -1.8 -23.6 
0.0045 0.416 0.636 -3.88 0.45 0.31 -2.4 -24.8 
0.006 0.459 0.700 -6.33 0.28 0.15 -3.9 -26.7 
1 -34.9 
F108 
0.0015 0.494 0.477 -4.90 0.29 0.30 -3.1 -24.6 
0.003 0.546 0.646 -4.50 0.39 0.26 -2.8 -25.2 
0.0045 0.570 0.733 -3.20 0.38 0.18 -3.2 -26.2 
0.006 0.571 0.785 -7.25 0.26 0.09 -4.5 -27.9 
1 -36.0 
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Table 3.18: Various physicochemical parameters (i.e., X", Xi", /3 	f 1, f 
and 4G,,, )for mixed CLP-nonionic surfactant systems. 
Mole 	X."' X;` f3" I; fi  
fraction (kJ mot-') (kI mot") 
T40 
0.0015 0.50 0.50 -3.71 0.40 0.39 -2.3 -24.2 
0.003 0.56 0.67 -4.81 0.39 0.22 -3.0 -25.8 
0.0045 0.66 0.74 -4.00 0.52 0.24 -2.4 -25.9 
0.006 0.57 0.79 -8.67 0.20 0.06 -5.4 -29.1 
1 -36.5 
T80 
0.0015 0.57 0.68 -4.37 0.44 0.25 -2.7 -25.6 
0.003 0.65 0.81 -2.84 0.71 0.30 -1.6 -25.8 
0.0045 0.70 0.86 -2.71 0.78 0.27 -1.4 -26.4 
0.006 0.61 0.89 -4.71 0.58 0.13 -2.7 -28.0 
I -38.4 
P85 
0.0015 0.45 0.34 -3.67 0.32 0.48 -2.3 -23.4 
0.003 0.51 0.51 -2.93 0.49 0.47 -1.8 -23.7 
0.0045 0.54 0.61 -4.41 0.39 0.28 -2.8 -25.2 
0.006 0.56 0.67 -4.31 0.43 0.26 -2.7 -25.5 
1 -34.9 
F108 
0.0015 0.49 0.45 -4.72 .0.29 0.32 -2.9 -24.5 
0.003 0.55 0.62 -4.14 0.42 0.29 -2.6 -25.1 
0.0045 0.57 0.71 -5.39 0.40 0.17 -3.3 -26.3 
0.006 0.57 0.77 -7.13 0.26 0.10 -4.4 -28-0 
1 -36.0 
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Table 3.19: Inter facia! composition (X' ,. interaction parameter (/3 C), activity 
coefficients (Jr) in mixed monolayer and surface properties (hmc, . , Amin , Gitlin and 
i.\U) Jor mixed ADP-nonionic surfactant systems. 
it r 	13 ? /1(I 	./.n Mole 
fraction 
0 
T40 
0.0015 
0.00 
0.0045 
0.006 
1 
I ncrc' 	1 U1, 
(mol m''`) 
~If/fl 
(/) 
1.73 95.75 
0.73 226.39 
0.78 213.72 
0.78 211.72 
0.80 208.79 
2.51 66.23 
J,nrn 
(kJ moI'') 
n 
OG,n 
(kJ mot') 
24.8 -34.6 
56.59 -63.6 
52.84 -62.3 
50.37 -65.0 
53.82 -59.8 
15.20 -50.3 
0.62 265.84 71.73 -64.3 
0.63 264.38 77.39 -60.9 
0.66 	. 252.71 71.77 -62.2 
0.70 238.11 68.55 -58.3 
3.18 52.26 12.27 -48.2 
0.2k) 580.26 143.47 -123.1 
0.3 470.01 105.73 -116.4 
0.38 431.53 97.21 -112.7 
0.47 351.56 89.04 -86.7 
1.23 134.96 28.08 -63.9 
0.34 495.15 131.67 -104.1 
0.34 487.69 126.31 -107.7 
0.35 472.18 127.98 -97.6 
0.60 227.64 66.05 -76.1 
0.75 220.58 51.15 -79.1 
T80 
0.0015 
0.003 
0.0045 
0.006 
1 
P85 
0.0015 
0.001 
0.0045 
0.006 
1 
F'108 
0.0015 
0.003 
0.0045 
0.006 
1 
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Table 3.20: hiterfacial composition (a" ' i, interaction parameter (,Q C ), activity 
coefficients (J,'') in mixed monolayer and .s surface properties (I„U1Y , A,71 j , G,rtn, and 
) Jor mixed NOT nonionic sur/ c'!aii! Systems. 
Mole 
fraction 
,~~ i° /3 c fjC r' rinu.. 	106 
(n1ol m) 
Arnrn 
(A'`) 
Umm  
(kJ mold ) (kJ mot") 
0 1.652 100.52 26.9 -36.5 
T40 
0.0015 0.615 -1.217 0.87 0.59 0.720 230.62 60.4 -62.7 
0.003 0.730 227.61 58.3 -63.7 
0.0045 0.731 227.13 57.6 -66.2 
0.006 0.703 -3.813 0.71 0.15 0.787 210.97 52.2 -63.5 
1 2.506 66.23 15.2 -50.3 
T80 
0.0015 0.633 -4.211 0.57 0.19 0.643 258.38 61.5 -72.5 
0.003 0.699 -3.861 0.70 0.15 0.656 253.28 61.2 -73.9 
0.0045 0.692 -5.133 0.61 0.09 0.694 239.21 55.9 -73.7 
0.006 0.857 -1.759 0.96 0.27 0.713 232.89 59.1 -67.2 
1 3.177 52.26 12.3 -48.2 
P85 
0.0015 0.376 	8.9-59 	32.7 3.55 	0.253 655.86 158.0 -141.1 
0.003 0.180 	6.139 	62.1 1.22 	0.282 588.76 139.9 -133.9 
0.0045 0.292 569.47 133.8 -137.9 
0.006 0.293 567.21 134.9 -130.9 
1 1.230 134.95 28.1 -63.9 
F108 
0.0015 0.322 516.37 136.8 -108.5 
0.003 0.393 422.72 101.8 -105.6 
0.0045 0.428 387.67 86.6 -104.6 
0.006 0.702 	-4.562 	0.67 0.11 	0.434 382.35 82.9 -106.2 
1 0.753 220.58 51.1 -79.1 
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Table 3.21: Inrerfacial composition (.1; 1, interaction parameter (j3 °), activity 
coefficients J i in Waited monolayer and surface properties (rr.....1 . fjnrrn• Gnrnr C1nd 
L\G )for mixed CLP-nonionic surfactant systems. 
Mole 
fraction 
l' p ° f ;  r,• 106  
(11101 ,112) 
Amirr 
(A2 ) 
Unrin 
(kJ roof') 
AG' )  
(kJ rnol*') 
0 - - 1.61 103.11 24.8 -34.5 
1'40 
0.0015 0.68 -3.95 0.67 0.16 0.68 241.32 66.9 -70.2 
0.003 0.64 258.26 65.3 -59.7 
0.0045 0.66 -7.01 0.44 0.05 0.72 230.55 60.5 -66.7 
0.006 0.73 228.42 59.6 -59.7 
1 2.51 66.23 15.2 -50.3 
T 80 
0.0015 0.82 -0.69 0.98 0.63 0.69 241.13 67.6 -59.7 
0.003 0.80 -2.11 0.92 0.26 0.70 238.50 61.8 -65.4 
0.0045 0.72 -5.15 0.67 0.07 0.73 228.92 55.2 -68.7 
0.006 0.69 -6.96 0.51 0.04 0.78 212.93 50.8 -68.3 
3.18 52.26 12.3 -48.2 
P85 
0.0015 0.61 -11.05 0.19 0.02 0.32 518.00 116.9 -131.0 
0.003 0.77 -4.52 0.79 0.07 0.33. 506.80 122.1 -118.3 
0.0045 0.70 -8.43 0.47 0.02 0.34 490.26 1 16.6 - 115.2 
0.006 0.64 -14.22 0.16 0.03 0.39 431.05 85.8 -124.1 
l 1.23 134.95 28.1 -63.9 
F108 
0.0015 0.32 521.8 138.3 -110.8 
0.003 0.33 508.54 131.3 -112.5 
0.0045 0.36 458.22 118.7 -105.9 
0.006 0.83 -4.01 0.88 0.07 0.55 303.42 73.4 -82.5 
1 0.75 220.59 51.2 -79.1 
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(B) Drug — Salt Systems 
In biological systems, growing of a bacterium is related to ion specificity 
[72]. The presence of an electrolyte in solution affects the behavior of amphiphiles 
which can be observed by studying the variation of cmc [73], aggregation number 
[74], morphological transitions/growth [75,76], dynamics of self-assembly 
[77,78], etc. Studies indicate that the ion specificity is a combination of various 
effects such as electrostatics, dispersion forces, thermal motion, hydrated ionic 
size, etc. [79-81]. The effect of different ions of same valency on the micellar 
properties of amphiphiles exemplifies the so-called Hofineister effect. 
There are several factors to decide the effect of salts on the structure and 
formation of micelles, such as chemical structure, nature (organic or inorganic), 
hydrated size of the counterions, etc. The effect of added salts on the micellization 
parameters has been attributed almost entirely to the counterion effect. Studies on 
surfactants have shown that the counterion exerts a strong influence on the cmc, 
aggregation number, size and shape of aggregates of ionic surfactant systems. 
The inorganic salts affect the ionic surfactant solutions through 
electrostatic interactions. The inorganic salts are mainly considered as thickening 
agents for surfactant solutions. It is well known that the structure of the micelle is 
controlled by the hydrated size of the counterions for inorganic salts and the 
counterions with higher hydrophilicity prefer to stay in the bulk of miecllar 
solution and therefore, are less effective to screen the charge on the nuceIlar 
surface. 
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Hydrotropes are another class of amphiphiles that become weakly surface 
active at high concentrations. They generally contain a benzene ring with or 
without an attached substituent group as hydrophobic moiety. This moiety is still 
smaller than that of drugs and, hence, the cmc values, which are also known as 
minimum hydrotropes concentration (mhc) for hydrotropes, are higher than those 
of drugs and surfactants. This mhc coincides with the change in slope of the plot of 
surface tension and log of hydrotrope concentration [82]- Hydrotropes have many 
practical applications which include separation processes [83], increase of cloud 
point [84], change in reaction rates [85], and use in pharmaceutical formulations 
[86, 87]. For example, sodium salicylate has been found to increase the solubility 
of tetnazepam [88]. Similarly, sodium salicylate and sodium benzoate are known 
to increase the solubility of diazepam in different solvents [89]. 
It is a well known fact that the solution properties of amphiphiles change 
drastically upon addition of another amphiphile. In a number of cases, synergism 
takes place and, as a result, both surface tension and cme decrease significantly 
[90-92]. Combining different amphiphiles thus widens the scope of producing a 
system with properties required for a particular application. With all these points 
in mind, we performed experiments on mixed systems of amphiphilic drugs and 
anionic hydrotropes at different stoichiometric mole fractions of hydrotropes. 
These hydrotropes, as mentioned in the preceding paragraph, are used in 
pharmaceutical formulations. Their use would reduce the undesirable effects of 
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drugs as well as the risk of precipitation of drug on its transition from liquid 
fornmlation to aqueous blood phase. 
Results and Discussion 
Addition of inorganic salts (NaCI, NaBr, KCI and KBr) as well as 
hydrotropes (NaSal, NaBenz and NaTos) decreases the emc of the drugs. Figs. 
3.29 to 3.36 depict the variation of cmc values of the three drugs with the 
concentration of added salts. 
Condensation of counterions at the positively charged drug head groups 
decreases the electrostatic repulsion among them and cme values decrease. Two 
mechanisms have been proposed for ions, behavior in micetlar systems: in one 
mechanism ions directly adsorb or desorb on the micellar surface and in another, 
ions affect the solvent property of water [93,94]. However, in general, it is 
proposed that kosmotropic ions (or structure-maker ions which exhibit strong 
interactions with water) bind less strongly to the micellar surface than chaotropic 
ions (or structure-breaker ions which exhibit weak interactions with water). 
Chaotropic ions are less hydrated and promote micellization and micellar growth 
[95,96]. Thus, an increase in hydrophobicity of the counterion increases the 
amphiphiles' tendency to micellize and result in erne lowering. 
The cmc values in NaCI are slightly different from the values in presence 
of KCI, whereas the values in presence of NaBr are not very different from those 
with KBr. The reason for this is that Nat1K` ions are coions for the cationic drug 
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micelles. However, slightly different values are due to the nature of these ions: 
these ions remain in aqueous phase and also affect the water structure. Hydrated 
radius of Na` ion is greater than that of KK ion (ru for Na4 ion is 3.82 A and for Kt 
ion is 3.31 A) [97]. Therefore, Na` reduces the availability of water in the head 
group region more than Kt ion. This increases the repulsions among the similar 
charged head groups. Hence, micellization becomes less favorable and reduction 
in one should be slower with Na' than with K. This indeed is observed in the 
present case. 
Cbmnge in counterion has greater effect on eme of the drugs. As Cl- (r j  
3.30 A) is more hydrated than Br(rh = 3.32 A) , the latter interacts more strongly 
with the cationic drug micelles, causing greater shielding of positive charge; this 
decreases the electrostatic repulsions more as compared to Cl-. Therefore, cmc 
decrease is more with Br than with Cl- (Figs. 3.29 to 3.32, Table 3.22). The 
effect of organic salts including sodium benzoate, sodium salicylate and sodium 
tosylate with an aromatic phenyl group the so called hydrotropes, has also been 
studied with amphiphilic drug systems. The organic salts may influence the 
morphology of micelles in a manner that depends upon the extent of their 
penetration into the micelles. The NaSal, NaBenz and NaTos decrease the cmc 
values and greatly enhance the tight packing of the cationic drugs at air-water 
interface. The self-aggregation of drug micelles in presence of organic salts is the 
resultant of both the electrostatic and hydrophobic interactions. In the absence of 
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salts, the charges on the drug head groups keep the drug molecules away from 
each other by means of electrostatic repulsion. Salts are added to screen the 
effective charges in the head group. Aromatic counterions have strong tendency to 
penetrate the head group region and thus there is micellar growth at lower loading 
of the micellar surface as compared to weakly penetrating inorganic counterions. 
Generally, it is found that the tine values decrease with increase in the 
concentration of the aromatic salts. The anion with more hydrophobic skeleton 
among organic salts gives rise to considerably lower eme's. Thus, the properties of 
aqueous solution of cationic drugs can be efficiently modified by the addition of 
salts, especially organic salts and large-sized inorganic salts. 
Representative plots of surface tension vs. log concentration for pure 
hydrotropes and for mixed systems (hydrotropes + drugs) at different mole 
fractions of hydrotropes are shown in Figs. 3.33 to 3.36. The variation of cmc and 
tint* for these mixed systems at different mole fractions of hydrotropes are 
recorded in Table 3.23. Regarding hydrotropes, the order of tint is NaSal (528 
mM) > NaBenz (382 mid) > NaTos (253 mM). NaBcnz contains a carbuxylate 
group t NaSal contains an additional OFT group whereas NaTos has a sulphonate 
group and a CH3 group. Hence, NaTos should be least hydrophilic and NaSal 
should be most hydrophilic among the three hydrotropes. Order of the one values 
confirms this. NaSal, the most hydrophilic one, forms aggregates at highest 
concentration. The tint values of the mixture are lower than the tint values of 
both drug and hydrotropes and decrease with the increase in stoichiometric mole 
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fractions (a,) of the hydrotropes. the mixed micelles ate formed due to 
synergistic interactions. The hydro ropes are in anionic form in aqueous media 
while drugs are in cationic form. Hence the systems show strong attractive 
interactions with the hydrotropes intercalating between the drug monomers 
[99,99]. This reduces the inlerhead group repulsions. Also the phenyl ring of the 
hydrotropes interacts with the ring part of the drug, strengthening the hydrophobic 
interactions. Hence cmc decreases. 'I lie decrease in cmc is maximum in NaBenz-
drug systems. For drug—NaTos system the values are close to NaBcnz system, 
whereas for drug—Nasal system the values are slightly higher. The difference in 
cmc* and experimentally obtained cmc (cmc) gives an idea about the nature of the 
mixed system. The values of cmc* in our case are always higher than the erne 
values which means that the mixed micelles are formed due to attractive 
interactions among the two components. 
The variation of cmc, cm c* , r„°  ,A,,,,, A G°,,, and AG°„a, are given in 
Tables 3.22 and 3.23. 
The adsorption efficiency at air/water interface of these drugs and effect of 
electrolytes on adsorption can be assessed in the light of the Gibbs adsorption 
equation (3.13). The variable n is introduced to allow for simultaneous adsorption 
of cations and anions. n is calculated by the equation proposed by Matejevic and 
Pethica [100]: n — 1 + m/(m + rn,), where in and m, are the concentrations of 
amphiphile and electrolyte, respectively. Thus n = 2 in water and approaches 1 in 
the presence of excess inert electrolyte. The dy/dlogC factor was obtained from the 
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slope of the linear part of y vs. log C isotherms. T,,,,,Y values were used to calculate 
minimum surface area per molecule, A,,,,,,. at the air/solution interface using the 
equation (3.14). 
The values of 1^„,,T and A,,,,,, are given in Tables 3.22 and 3.23. We can 
see that 1 „,,.Y increases with the addition of salt. In general, the drugs positive ions 
in the micelle Would attract counterions in order to compensate the headgroup 
cnulombic repulsion. making the micelle as well as the monolayer formed stable 
and compact. hence. I,,,,Y increases. Among Cl- and Br- ions, as Br- ion is less 
hydrated than Cl- ion, it affects the headgroup region more and the T,,ar is more in 
its presence. Change in colon (i.e., Na or K) is relatively ineffective. As 
values are inverse of 1,_, values, the behavior of A,,,,,, is self-explanatory in the 
light of the discussion for T. 
The evaluated values of T;„ for drug—hydrotrope surfactant systems is 
given in Table 3.23. As is clear from the data in the Table, the value for drug-
hydrotrope mixtures increases with increases in a i . Figs. 3.37 to 3.38 show the 
values of I ; L, and A,,,,. As .9, 	is inversely related to r 	the decreasing trend is 
as expected. Both the components are oppositely charged and hence their mixing 
results in densely packed surface due to reduction in head group repulsions. That 
is why I,, increases and A,,,, decreases, the two Components can come closer to 
each other in comparison to individual components. However, two points need to 
be discussed: (i) the value of 1: 	decreases with the first addition, i.e., at lowest 
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a, taken and (ii) the values are, in general, lower than I; of pure components or 
in other words, A,,,,, first increases at a, = 0.012 and then decreases and A,;„ is 
higher than that of pure components. As structures of both components are 
dissimilar, addition of hydrotrope (in small quantity) disturbs the molecular 
arrangement at the interface. Hence, molecules move slightly apart from each 
other. As a result, A,,,, increases (or F. decreases). However, as more and more 
hydrotrotopes are added (i.e. higher aI values) the interaction among the two 
components dominates and molecules again come closer. However, the Im. (or 
A„,;„) values always remain lower (or higher) than those of pure components. 
Presence of hydrotrope decreases the repulsion among two drug molecules by 
intercalating between drug molecules and should decrease the Amin. But presence 
of hydrotropc at the interface increases the area as it also occupies some area. 
Similar expansion in minimum area was observed by other workers also [101, 
102]. 
Values of molar free energy at the maximum adsorption attained at cmc, 
G„,;,, [26] are also given in Table 3.23. It is the work required to make an interface 
per mole. The lower the value of G,„,„, the more stable surface is formed. The 
values of G,„,n decrease with increase in at which supports our assertion that 
addition of hydrotropes makes the system more stable. 
All the negative AGI'a, values for inorganic salts which were calculated 
using equation (3.16) and listed in Table 3.22 imply that the adsorption of the 
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amphiphilic molecules at the airlwater interface take place spontaneously. The 
standard Gibbs energy of micellization, AG', was evaluated using the equation 
(3.8). The AG a (Table 3.22) values are all negative suggesting the process of 
micellization to be spontaneous. The absolute values increase with the increase in 
concentration of added salts. As already explained, presence of the salt ions 
decreases the repulsions among head groups. This, in turn, decreases the factor 
opposing the process of micellization and micelle formation becomes easier. 
The magnitude of (AG) is lower for hydrotropes than for drugs (Table 
3.23). The values for drug-hydrotrope systems are closer to that of drugs. The 
magnitudes are larger than that of drugs. This again confirm the order of systems 
stability as hydrotropes < drugs < drug—hydrotropes. AG°, is greater in CLP- 
hydrotrope systems. The oGmvalues can be used to calculate the standard Gibbs 
energy of adsorption (G°„)  through equation (3.16), where the second term on 
right hand side of this equation is the work involved in going from zero surface 
pressure to surface potential at erne at constant T . value. These values too are 
negative and lower than AG, (the ratio of AG.' to zG,° is greater than 1.5, Table 
3.23). This indicates that the molecule's hydrophobicity leads them toward the 
air/solution interface and only after its saturation micelle formation takes place. 
As discussed earlier, hydrotropes have additional hydrophobic 
interactions beside electrostatic one, which leads to the formation of more stable 
mixed systems with cationic drugs due to synergistic interactions. Thus, a mixture 
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of hydrotropes with cationic drugs leads to the formation of mixed aggregates 
because of the different surface activity of the components. 
Mixed micelles formed in the solution of such non homogenous surface 
active materials are expected to be nonideal. The nonideal mixing is quantified on 
the basis the regular solution theory (RST) as already discussed earlier. 
The X, values (Tables 3.24 to 3.26), calculated using equation (3.2) 
increase with increasing a, and the trend is: NaSal < NaBenz NaTos. Due to the 
hydrophilic nature, NaSal participates less in mixed micelle formation in 
comparison to NaBenz or NaTos. On the other hand, the X;° values increase with 
increasing content of hydrotropes in solution. However, the values are smaller 
than both a, and X. . Ideally, the mixed micelles should contain only drug as 
drugs are hydrophobic and their molecules would form aggregates readily. As 
hydrotropes are also slightly amphiphilic in nature they also contribute in micelle 
formation increasing the aggregates hydrophobicity making mixed micelles more 
stable. Thep'" values are negative for all systems and their large magnitudes 
suggest strong synergism in the mixed systems. The $o, values follow a trend 
similar top ;. For ADP—hydrotrope and NOT— hydr'otrope systems, the values are 
almost equal, whereas, for CLP—hydrotropes the value changes from - -9 to 
— -15/-14 f'^ values. (see Tables 3.24 to 3.26). These values suggest that although 
the hydrotropes are taking only little part in mixed micellization, due to their 
anionic nature, they interact strongly with the cationic drug molecules. Values of 
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i;"' and f,"' (activity coefficients of hydrotropes and drugs) indicate that 
hydrotorpes are far from their standard state while drugs are very close to standard 
state. 
The excess free energy of micellization (OG') values are also negative 
and the magnitude increases with the increasing content of hydrotrope in the 
solution. This indicates that hydrotrope addition increases the hydrophobic 
interactions and makes the mixed micelles more stable than the micelles of 
individual components. The value of AGu is greater in case of CLP—hydrotrope 
systems. 
The interactions among the two mixed components can be analyzed 
using Rosen's mode [ 12]. This model gives mole fraction of one component in 
mixed monolayer ( X') as well as the nature and strength of interactions. If the 
interaction parameter, 5a,  comes out to be equal to zero, the interaction among the 
two components is taken as zero, that is the mixing is ideal. Negative Q° values 
indicate attractive while positive values mean repulsive interactions. 
The values of X,° (Tables 3.24 to 3.26) increase with increasing c value. 
This means that the two components are forming mixed micelles with increasing 
content of hydrotrope. In ADP—hydrotrope and NOT—hydrotrope systems, X,° 
value shows no definite trend and vary slightly with salt type. However, in CLP-
hydrotrope systems, Xvalues are in the order of NaSal < NaBenz < NaTos. As 
NaTos is most hydrophobic among the salts used, it tries to penetrate the drug 
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micelles and forms mixed micelles more readily than NaSal (which is most 
hydrophilic). The /3a values calculated using X,° values, come out to be negative. 
Average Q° values are almost equal for the three ADP—hydrotrope and NOT-
hydrotrope systems. For CLP—hydrotrope systems, the magnitude of ,8 . varies in 
the order: NaSal < NaTos < NaBenz. With cationic surfactants (both conventional 
and gemini) NaSal have been found to interact most strongly [98, 99]. It was 
proposed in those studies that Sal- ions intercalate between the surfactant head 
groups in such a way that COO- group of one micelle interacts with the head 
groups of another micelle and thus form a chain of micelles. As the drugs are also 
cationic, we expect the interaction in drug—NaSal systems to be strongest. 
However, we obtained opposite results; NaSal is interacting weakly 
(comparatively) with these drugs. Probably the rigid and short hydrophobic parts 
of the drugs experience steric repulsion with the short ring structure of the 
hydrotropes. 
Values of activity coefficients f,° and f2 of the two components at the 
interface can be seen in Tables 3.24 to 3.26. It is evident that these values are less 
than unity indicating nonideality in the solution. The values of f,° (the activity 
coefficient of hydrotropes) are very low which suggest that hydrotropes are far 
away from their standard state in mixed micelles whereas drugs are comparatively 
much closer to this state (_f are greater than f ' and in some systems are close to 
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Table 3.22: Values of cmc, Im. , Amin , AG,,  OG O  for drugs- inorganic salts 
systems. 
Additive 	cmc 	rmax • 106 	Amrn 	AG° 	AGO m ads 
(MM) 	(MM) 	(mol m,`) 	(A2) 	(kJ mol) (kJ mole ) 
ADP/NaC1 
0 41.0 1.734 95.75 -18.2 -34.6 
50 33.75 2.249 73.87 -18.7 -32.0 
100 30.78 2.261 73.36 -18.9 -32.9 
150 28.40 2.277 72.75 -19.1 -34.2 
200 25.70 2.289 72.36 -19.3 -33.1 
wDPJKCI 
50 31.99 2.348 70.63 -18.8 -32.1 
100 28.84 2.391 69.55 -19.0 -32.4 
150 27.75 2.405 69.23 -19.1 -33.3 
200 25.02 2.413 68.93 -19.4 -34.0 
ADP/NaBr 
50 29.74 2.524 65.81 -18.9 -32.5 
100 26.61 2.539 65.27 -19.2 -32.6 
150 24.74 2.573 64.53 -19.4 -32.9 
200 22.82 2.602 63.88 -19.6 -33.0 
ADP/KBr 
50 28.18 2.645 62.99 -19.1 -31.9 
100 25.31 2.653 62.61 -19.4 -32.2 
150 23.62 2.669 62.08 -19.5 -32.3 
200 20.11 2.692 61.63 -19.9 -32.5 
NOT/NaCI 
0 20.8 0 1.652 100.52 -19.9 -36.5 
50 16.53 2.160 77.92 -20.6 -35.0 
100 15.02 2.162 76.77 -20.7 -35.0 
150 12.35 2.199 75.49 -21.2 -36.2 
200 9.36 2.219 74.83 -21.9 -37.2 
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N OT/KCI 
50 15.80 2.258 73.52 -20.6 -34.7 
100 15.50 2.292 72.43 -20.6 -34.6 
150 12.06 2.305 72.04 -21.3 -35.5 
200 9.13 2.311 71.84 -21.9 -36.7 
NOT/NaBr 
25 18.65 2.547 65.18 -20.2 -32.1 
50 14.02 2.586 64.27 -20.9 -33.8 
100 12.77 2.587 64.17 -21.1 -34.5 
NOT/KBr 
25 16.34 2.631 63.11 -20.5 -33.2 
50 15.37 2.633 63.07 -20.6 -34.3 
100 11.78 2.653 62.59 -21.3 -34.9 
CLP/NaCl 
0 18.48 1.610 103.11 -20.2 -34.5 
50 12.28 2.014 82.44 -21.2 -37.1 
100 10.21 2.042 81.30 -21.7 -37.7 
150 9.24 2.103 78.93 -22.9 -37.9 
200 6.51 2.111 78.64 -22.8 -38.9 
CLP/KCI 
50 11.68 2.143 77.47 -21.3 -36.5 
100 10.20 2.184 76.03 -21.7 -37.2 
150 7.98 2.203 75.36 -22.3 -37.5 
200 5.26 2.248 73.86 -23.3 -38.7 
CLP/NaBr 
25 13.89 2.567 64.62 -20.9 -34.4 
50 9.47 2.593 64.04 -21.9 -35.5 
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Table 3.23: Values of f cmc, cmc *, T,,,,,C , Amin , JG' , A G ads, and Gmin for drugs-
hydrotropic surfactant systems 
Mole 
fraction 
CmC 
(mM) 
Cmc*  
(mM) 
Tn. .106 
(mol m 2 ) 
Amin 
(A2) 
OGm 
(k3 mo1-1) 
AGa 
(k3 mol-') 
Gmin 
(1c1 mol'1 ) 
.ADP/Nasal 
0 41 1.734 95.75 -18.2 -34.6 24.8 
0.012 34.38 41.45 1.692 98.13 -18.6 -32.4 28.4 
0.024 26.75 41.93 1.716 96.74 -19.3 -34.4 25.7 
0.036 23.86 42.40 1.893 89.74 -19.6 -34.7 23.7 
0.048 16.66 42.89 1.875 88.54 -20.4 -33.1 24.3 
1 528 1.761 94.30 -11.8 -24.8 26.9 
ADP/NaBenz 
0.012 36.60 41.44 1.378 120.43 -18.5 -34.4 35.2 
0.024 30.80 41.89 1.364 121.68 -18.9 -33.7 36.6 
0.036 17.18 42.36 1.392 119.25 -19.3 -36.6 34.7 
0.048 9.02 42.83 1.403 118.38 -22.0 -40.0 32.1 
1 382 1.518 109.35 -12.6 -23.4 35.4 
ADP/NaTos 
0.012 33.96 41.41 1.409 117.86 -18.6 -34.7 33.7 
0.024 29.45 41.83 1.491 111.36 -19.0 -35.3 32.0 
0.036 15.73 42.26 1.549 107.18 -20.6 -36.8 30.3 
0.048 13.18 42.72 1.681 98.79 -21.0 -35.8 27.4 
1 253 1.861 89.23 -13.8 -27.7 23.9 
NOT/Nasal 
0 20.80 1.652 100.25 -19.9 -36.5 26.9 
0.012 18.39 21.04 0.944 175.81 -20.2 -52.2 42.5 
0.024 14.79 21.29 1.068 155.42 -20.7 -53.2 34.2 
0.036 12.49 21.55 1.176 141.13 -21.2 -47.3 34.0 
0.048 9.55 21.81 1.208 137.44 -21.9 -43.4 36.4 
1 528 1.761 94.30 -11.8 -24.8 26.9 
NOT/NaBenz 
0.012 18.00 21.04 0.869 191.12 -20.2 -48.3 52.4 
0.024 15.04 21.28 1.154 143.83 -20.7 -43.3 38.3 
0.036 12.46 21.53 1.157 143.44 -21.2 -40.1 42.4 
0.048 8.19 12.79 1.539 107.87 -22.2 -39.5 29.6 
1 382 1.518 109.35 -12.6 -23.4 35.4 
NOT/NaTos 
0.012 17.63 21.03 1.256 132.18 -20.3 -45.1 31.1 
0.024 13.49 21.27 1.165 142.53 -21.0 -51.8 31.9 
0.036 12.15 21.51 1.159 143.24 -21.3 -51.0 32.4 
0.048 9.54 21.75 1.434 115.75 -21.9 -47.4 25.2 
1 
1 
253 1.861 89.23 -13.8 -27.7 23.9 
CLP/NaSal 
0 18.48 1.610 103.10 -20.2 -34.5 29.2 
0.012 14.70 18.70 0.464 357.74 -20.8 -70.3 99.3 
0.024 12.28 18.92 0.486 341.71 -21.2 -70.6 95.7 
0.036 9.39 19.15 0.489 339.40 -21.9 -73.1 95.0 
0.048 7.58 19.38 0.509 326.05 -22.4 -70.5 93.3 
1 528 1.761 94.30 -11.8 -24.8 26.9 
CLP/NaBenz 
0.012 5.27 18.69 0.459 361.42 -23.4 -68.0 110.5 
0.024 3.15 18.91 0.629 263.90 -24.6 -63.5 74.2 
0.036 2.66 19.14 0.645 257.21 -25.1 -64.6 70.5 
0.048 1.93 17.37 0.780 212.83 -25.9 -57.3 60.9 
1 382 1.518 109.35 -12.6 -23.4 35.4 
CLP/NaTos 
0.012 5.91 18.69 0.442 375.94 -23.0 -82.3 103.0 
0.024 4.22 18.90 0.527 315.15 -23.9 -75.7 84.4 
0.036 3.96 19.11 0.532 311.91 -24.1 -71.8 85.7 
0.048 1.86 19.34 0.860 193.10 -26.0 -63.1 46.5 
1 253 1.861 89.23 -13.8 -27.7 23.9 
Table 3.24: Various phtsicochemical parameters (X,"' 	 fire , f,"' , f,°' 
A G" X ° , /3 ° , f,° and fz) for ADP- hvdrotropic surfactant systems. 
Fraction 
m 
 1 
td 
I 
m ('m 
✓ I f
'^ 
2 `,Gex 
(kJ mol') 
x;' 1 /~ /~ fl f(' 2 
NaSal 
0.012 0.109 0.001 -6.2 0.007 0.93 -1.5 
0.024 0.183 0.002 -7.5 0.007 0.78 -2.8 0.17 -7.6 0.005 0.80 
0.036 0.210 0.003 -7.8 0.008 0.71 -3.3 0.19 -7.8 0.005 0.74 
0.048 0.262 0.004 -9.5 0.006 0.52 -4.6 0.23 -8.6 0.006 0.63 
NaBenz 
0.012 0.089 0.002 -5.1 0.013 0.96 -1.0 0.14 -7.9 0.003 0.86 
0.024 0.154 0.003 -6.1 0.013 0.87 -2.2 0.11 -6.2 0.010 0.93 
0.036 0.258 0.004 -9.2 0.005 0.57 -4.4 0.12 -5.8 0.010 0.93 
0.048 0.315 0.005 -9.9 0.004 0.31 -6.5 0.29 -12.5 0.002 0.36 
NaTos 
0.012 0.118 0.002 -5.4 0.015 0.93 -1.4 
0.024 0.170 0.004 -5.8 0.018 0.84 -2.1 
0.036 0.275 0.007 -8.9 0.009 0.51 -4.5 0.21 -6.6 0.02 0.75 
0.048 0.298 0.009 -9.6 0.009 0.43 -5.0 0.27 -8.4 0.79 0.54 
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f Table 3.25: various physicochemical parameters (X, , X;` , Qm f,m , 2°' 
OGe X ° , /3 ° , f° and f)for NOT- hydrotropic surfactant systems. 
Mole T X d X i m Q m fi m fz o ~Ge O x i O Q O fi O .fz 
fraction (U mo1-t ) 
NaSal 
0.012 0.086 0.0005 -6.36 0.005 0.95 -1.3 0.25 -13.55 0.0004 0.43 
0.024 0.158 0.0010 -7.71 0.004 0.82 -2.6 0.30 -15.99 0.0004 0.23 
0.036 0.197 0.0015 -8.44 0.004 0.72 -3.4 0.26 -12.30 0.0040 0.43 
0.048 0.239 0.0020 -9.72 0.004 0.57 -4.5 0.25 -10.55 0.0025 0.52 
NaBenz 
0.012 0.095 0.0007 -6.26 0.006 0.94 -1.4 0.01 -3.12 0.046 0.99 
0.024 0.158 0.0013 -7.22 0.006 0.84 -2.5 0.16 -8.75 0.002 0.79 
0.036 0.201 0.0020 -8.06 0.006 0.72 -3.3 0.18 -8.79 0.003 0.75 
0.048 0.260 0.0027 -10.1 0.004 0.51 -4.9 0.24 -10.82 0.002 0.54 
NaTos 
0.012 0.105 0.0011 -5.95 0.009 0.94 -1.4 0.28 -13.64 0.001 0.33 
0.024 0.186 0.0022 -7.40 0.007 0.77 -2.8 0.31 -13.63 0.001 0.26 
0.036 0.211 0.0033 -7.60 0007 0.71 -3.2 0.32 -14.42 0.002 0.21 
0.048 0.251 0.0044 -8.65 0.009 0.58 -4.1 0.33 -13.87 0.002 0.22 
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Table 3.26: Various physicochemical parameters (X; , X;a ,5 	f m , f2 
X; , Q °, A° and f z°)for CLP- hydrotropic surfactant systems. 
Mole
fraction 
m 
X 1 X 
;a 
~ 
m Q f m 
~ 
f
z
m o 
(kJ mol"') 
a 
X I 
a l~ o f ~ 
v f z 
NaSal 
0.012 0.12 0.0004 -7.65 0.003 0.89 -2.1 0.08 -6.08 0.006 0.97 
0.024 0.17 0.0009 -8.29 0.003 0.79 -3.0 0.13 -6.81 0.006 0.89 
0.036 0.22 0.0013 -9.63 0.003 0.62 -4.2 0.16 -7.14 0.006 0.83 
0.048 0.25 0.0018 -10.48 0.003 0.92 -5.0 0.24 -9.72 0.004 0.57 
NaBenz 
0.012 0.27 0.0006 -13.88 0.001 0.36 -6.9 
0.024 0.31 0.0012 -15.45 0.001 0.23 -8.3 0.28 -14.43 0.001 0.32 
0.036 0.33 0.0018 -15.73 0.001 0.21 -8.7 0.32 -16.90 0.001 0.18 
0.048 0.34 0.0024 -16.63 0.001 0.15 -9.4 0.32 -16.16 0.001 0.19 
NaTos 
0.012 0.27 0.0010 -12.42 0.001 0.42 -6.2 0.27 -12.15 0.002 0.41 
0.024 0.30 0.0019 -13.30 0.001 0.30 -7.1 0.33 -15.10 0.001 0.19 
0.036 0.31 0.0029 -13.09 0.002 0.28 -7.1 0.32 -13.11 0.002 0.26 
0.048 0.35 0.0039 -16.21 0.001 0.14 -9.3 0.34 -14.10 0.002 0.20 
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Chapter-IV 
Sotubilization of Phenytoin ( 2) by Cationic Gemini 
Surfactants (16-s-16 ancf 14-s-14, s = 4,5,6) and their 
Binary Mixtures with nonionic Surfactants 
Low aqueous solubility is usually a major hurdle in development of new 
pharmaceutical compounds as many problems like chemical solution preparation 
and designing of liquid drug formulation depend on drug's aqueous solubility. A 
large number of drugs fail to proceed beyond the initial stages because of their low 
aqueous solubility. Different methods used to modify drug solubility include use 
of cosolvents [1],  selection of salt form [2], change of crystal form [3], preparation 
of solid dispersion [4], particle size reduction [5], complex formation [6,7] and use 
of prodrugs [8,9]. Micellar solubilization is another method for enhancing the 
drugs' solubility [ 10]. Micelles protect drugs from destructive factors upon 
parenteral administration, modify their biodistribution [ 11,12], and their (micelle) 
sizes permit them to accumulate in areas with leaky vasculature, at the same time 
avoiding uptake by reticulendothelial system [ 13]. Micellar formulation has less 
tendency of precipitation on dilution. They physically entrap sparingly soluble 
pharmaceuticals and deliver them to the desired site of action at concentration that 
can exceed their intrinsic aqueous solubility and thus can increase bioavailability. 
The undesirable side effects are lessened, as contact of the drug with inactivating 
species such as enzymes present in biological fluids are minimized, in comparison 
with free drug [ 14]. 
Common surfactants used in micellar formulation are either amphoteric, 
nonionic, copolymer or ionic. Micellar properties of nonionic surfactants depend 
mainly on the ability of hydrocarbon core of the micelles to dissolve a nonpolar 
solute. Thus, the solubilization capacity of the solute is controlled mainly by the 
core volume. However, materials with some polarity such as benzoic acid, are 
absorbed at the interface between the core and the hydrophilic layer of the micelle 
[1]. Hence, the solubilization capacity is less controlled by the core and more 
dependent on the polar head group of the surfactants. 
Saket [15J studied the miccilar solubilization of mecolazine hydrochloride 
which is slightly water-soluble. The drug was solubilizcd in a series of different 
nonionic surfactant solutions, including Tweens and Brijs. The results showed that 
the longer the hydrocarbon chains in homologous series, the more efficient in the 
solubilizing power. Tween 80 is more efficient as solubilizcr than Tween 20, and 
Brij 58 is more efficient than Brij 35, indicating that the drug is incorporated in the 
core more than the capsular region of the micelles. 
Polymeric micelles are safer for parenteral administration than solubilizing 
agents currently in use like polyethoxylated castor oil (Cremophor EL) or 
polysorbate 80 (Tween 80) [16-19]. Polymeric micelles are kinetically stable so 
they dissociate slowly, even at concentrations below the cmc, extending 
circulation times in blood [19]. In addition, they have larger cores than surfactant 
micelles, leading to higher solubilization capacity than the regular micelles [19]. 
Gemini surfactants are better solubilizers [20-22] as they have better surface 
active properties than the corresponding conventional surfactants of equal chain 
length. Differently from conventional surfactants, gemini surfactants consist of 
two hydrophobic groups, two hydrophilic groups and spacer linked at or near head 
groups [23,24]. As a result, gemini surfactants form larger micelles than the 
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conventional surfactants and thus should have a better solubilizing capacity. The 
benefit of these surfactants (Tweens, copolymers and geminis) over traditional 
surfactants is potential for much lower cmc's. Amphiphiles having high cmc may 
not be suitable drug-targeting devices since they are unstable in an aqueous 
environment and easily dissociate upon dilution. 
Phenytoin (PHT) was introduced in 1938 as an antiepileptic drug. It has the 
advantage over barbiturates in that it does not produce the sedation seen with those 
agents. Since its introduction, PHT has become the drug of choice in the treatment 
of grand mal epilepsy. Although the drug is commonly used orally for the chronic 
control of seizures, it is administered parenterally in certain instances. The 
intravenous route is recommended for the treatment of status epilepticus and the 
intramuscular route is recommended for prophylaxis against seizures or in patients 
who cannot take the drug orally [25]. The prophylactic use of PHT may be 
necessary in epileptic patients prior to surgery, to prevent seizures during 
neurosurgery or in preventing seizures which may result from acute bacterial 
meningitis [26]. 
The poor solubility of PHT has led to problems in both the formulation of 
suitable dosage forms and in achieving a uniform and predictable bioavailability. 
Since the drug is a weak acid with pKa of 8.3 [27], it is largely unionized in the 
physiological pH range. The solubility of the unionized acid has been reported to 
be between 14 to 20.5 pg/ml [27.28]. The poor solubility of P1-IT is a result of its 
high melting point, 297 °C, and its highly hydrophobic nature. The bioavailability 
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of PHI by the oral route of the administration has been the subject of numerous 
studies. The drug is most commonly administrated as the sodium salt to further 
increase its solubility. 
RESULTS AND DISCUSSION 
Surfactant-surfactant interactions 
The cmc values of the studied single as well as mixed surfactant systems 
are presented in Table 4.1, which were obtained from the plots shown in Figs. 4.1 
and 4.2. The values for pure surfactants are in good agreement with the literature 
values. The ideal eme values, cmc* for mixed surfactant systems calculated using 
the Clint equation (3.1), are also included in Table 4.1 (Figs. 4.3 and 4.4). All the 
observed cmc values were found to be lower than ideal one values, indicating 
negative deviation from ideal behavior for the mixed micelle formation. The 
estimate of negative deviation of experimental cme values from cme* and, hence, 
nonideality of mixed binary surfactant systems can be made in light of Rubingh's 
equation (3.3). The interaction parameter, (3'", accounts for deviation from ideality 
and is an indicator of the degree of interaction between two surfactants in mixed 
micelles. The values of /s'" along with the micellar mole fraction, X,'n  , and activity 
coeflicient, f;"', of the ith surfactant within mixed micelles calculated using 
Rubingh's treatment are presented in Table 4.1 for the selected equimolar binary 
surfactant systems. The negative values of (1'" indicate synergistic interactions. It 
is well-known [30, 31 ] that for ionic-nonionic mixed surfactant systems significant 
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electrostatic self-repulsion of Ionics and weak steno self-repulsion (depending on 
the head group size) of nonionics before mixing are weakened by dilution effects 
after mixing and that the electrostatic self-repulsion of the ionic surfactant is 
replaced by the ion-dipole interactions between the hydrophilic head groups of 
ionic and nonionic surfactants. Synergism in surfactant mixtures depends not only 
on the strength of interactions but also on the relevant properties of surfactants. 
Least synergism is observed with geminis-F108 and highest with geminis-Tween 
40. F108, with polyoxyethylene (POE) groups, has a large number of oxygen 
atoms with lone pair of electrons. Thus, it should have a tendency to react 
eoulombically with the cationic geutini surfactant; but the presence of long 
polyoxyethylene head group imposes some steric constraint due to thermal 
vibrations, restricting the effective head group interactions, hence showing lesser 
value of interaction parameter. The values of /3'" were used to find activity 
coefficients of the components in micelles (f; f") (equations (3.5) and (3.6). 
The values of activity coefficients are less than unity in all systems indicating non-
ideality in mixed micelles. 
The liquid/air interface of a surfactant solution is well populated by the 
adsorbed molecules. The surfactant concentration is always more at the interface 
due to adsorption as compared to the concentration of the surfactant in the bulk. 
The maximum surface excess concentration at the air/water interface, I.., was 
evaluated by the Gibbs adsorption equation (3.13) and equation (3.14) was used to 
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calculate the A,,,,,,. The values of [,n,. (and also of A,,,;,,) are given in Table 4.1. 
For mixtures of geminis-nonionic surfactants the value of n was 4 whereas for 
pure nonionic and gemini surfactant n was 1 and 3, respectively. The values of 
I',  in all systems were lower than that of nonionic surfactants, except in F108. 
The geminis have chain lengths of 14 and 16 carbons while Tween 40 and Tween 
80 have 16 and 18 carbons in their tails. The dissimilarity in tail length with 
Tween 80 (with 18 carbons) is more than with Tween 40 (with 16 carbons). 
However, in Tween 80, presence of double bond slightly decreases the effect of 
chain length. On other hand the dissimilarity of the hydrophobic part of F108 poly 
(propyleneoxide) with geminis is more than the Tweens . When the chain lengths 
are dissimilar, the molecules above the height of adjacent molecules (of second 
component) will exhibit thermal motion. This thermal motion disturbs the surface 
causing loose packing (i.e., small [',,,ax ) and large area per head group. The A,,,;,, 
values for mixtures are greater than pure components. As the mixtures contain a 
gemini and nonionic surfactant, the I',,,;,, (or Amin)  are expected to increase (or 
decrease). Adsorption of nonionic surfactant molecules between the positively 
charged molecules of gemini surfactants should decrease the repulsion among 
them and the inter head group distance should decrease. However, what we 
observed experimentally is an increase in A,,,,,. The large hydrophilic group of 
Tweens and F108 as well as head-spacer-head configuration of geminis causes 
steric hindrance and the two molecules would be far apart from each other. 
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Although the intercalation of nonionic component between the two ionic 
surfactant molecules decreases the repulsion among them, the large hydrophilic 
group of nonionic component increases the overall area per head group. 
The X,° values (Table 4.2) are greater than a, and are smaller than X," 
values. This means that the mixed micelles have greater contribution of nonionic 
surfactants than mixed monolayers. In other words, mixed monolayers contain 
more gemini as compared to mixed micelles. Rigid head group structure of 
geminis make it easier for them to accommodate at the planar air/water interface 
rather than to adjust in a curved micellar surface. Also, Tweens and Fl 08 have 
long hydrophobic tails and adsorption of these surfactants on the interface with 
these long tails above the interface would make the surface unstable and hence 
these surfactants would prefer micelle formation. 
The J? values are negative at all studied systems (Table 4.2), indicating 
attractive interactions among the components in the mixed monolayers. 
Activity coefficients of the two components (fi" /0)  are obtained by 
equations (3.11) and (3.12) and are listed in Table 4.2. These values are always 
less than unity suggesting nonideal mixing behavior. The f" values are greater 
than f ° values indicating nonideality in the mixed monolayer 
The values of excess Gibbs energy of micellization, OGG, calculated by 
equation (3.7), are listed in Table 4.3. These values cone out to be negative 
because stable mixed micelles are formed spontaneously. 
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The AG;', are negative indicating that the process of micelle formation is 
spontaneous. This is understandable as presence of nonionic surfactants in 
between the head groups of geminis reduces the electrostatic repulsion and makes 
the process more spontaneous. The L\G; values were further used to calculate 
the standard free energy of adsorption (using equation (3.16)), which are 
also negative and are larger in magnitude than AG . This suggests that molecules 
prefer to adsorb at the interface due to their hydrophobicity and after the saturation 
of interface these molecules aggregate to form micelles. 
The Gn,;,, values, calculated by equation (3.17) ( Table 4.3), come out to be 
positive. The lower the value, the more stable is the surface formed. Among pure 
components. Tween 40 forms most stable surface. Tween 40 has smallest chain 
which, although decreases the hvdrophohicity of the molecule, makes its surface 
adsorption easier. Too long chain makes it difficult for the molecule to remain 
above water with the chain towards air. 
Molar Solubilization Ratio (\ISR) and \licelle Phase/Aqueous Phase 
Partitioning of HIT 
measure of the ettecti enc s of a surfactant in soluhilizing a <givenl 
solubilizate is the molar Sohlhilization ratio (.Il5R) equivalent to increase in 
solubilizate concentration per unit increase in 1»icellar surfactant concentration. In 
presence of excess of hydrophobic organic compound.1/SR. given by the equation 
(4.1) [31-33] 
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t1SR = ([Sr] - (S,j) / (C-, - 
	 (4.1) 
is obtained from the slope of the curve that results when solubilizate concentration 
is plotted against surfactant concentration. [.S,] is the total apparent solubility of 
PI-IT in single/mixed surfactant solutions at a particular total surfactant 
concentration. C. above cmc and [S,,,,,) is the apparent solubility of PHT at cmc 
which is taken as its water solubility, [S], since it changes only very slightly up to 
the cmc of surfactant. 
An alternative approach used to quantify the surfactant solubilization is 
based on the micelle-water partition coet'ticicnt (h';,,), which represents the 
distribution of the organic compounds betweensurfactant micelles and the 
aqueous phase and ma \ he expressed as follows [34] 
(4.2) 
\\here X,,; and X, are the mole fraction of solute in the micelle and aqueous phases, 
respectively. The value of X„ can be calculated using AISR by the equation (4.3) 
X.;=.1LSR/(I+.WSR ) 	 (4.3) 
Fhe mole fraction of organic compound in the aqueous phase (X,) was estimated 
as 
.':= [5'. 	 (4.4) 
where 1 , is the molar \ olunle of \\ ater (().()1807 d m mol) at 30 "C. With these 
expressions. K,,, becomes 
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.fI.SR ; [5,,,,, ] V(1—.1ISR 
	
(4.5) 
The aqueous solubility of PHT increases linearly over the range of single or 
mixed surfactant concentrations above cinc indicating its solubility enhancement 
in water. The MSR calculated from equation (4.1) and K,,, of PI-IT in gemini-
nonionic surfactants with equimolar mixtures are listed in "Fable 4.4. Among the 
single surfactant systems. MSR is found to be in the order F 108 > Tween 80 
=-Twwween 40 > 16-6-16 >16-5-16 >16-4-16 '14-6-14 >14-5-14 > 14-4-14 and K,,, 
also found to be in order F108 >Tween 80 = Tween 40, 16-6-16 >16-5-16 >16-4-
16,  14-6-14 >14-5-14 >14-4-14. Higher solubilization power of F 108 compared to 
Tween 80 and Tween 40 may be due to the greater number of oxyethylene (OE) 
units in it. which may facilitate solubilization of the drug due to hydrogen bonding 
between MITand (OE) head groups at the interfacial region. On the other hand, 
the higher solubilization power ut I vv een SO compared to Tween 40 may be 
referred to hydrocarbon chain length of hydrophobic part of surfactant (1>}. 
Nonionic surfactants F 108 and Tweens have higher Av1SR and K, for PHI' than the 
cationic surfactants (16-s-16 and 14-s-14 ). 
Solubility of PHT in mixed 16-s-16 nonionic and 14-s-14/nonionic 
surfactants systems were determined and compared with those in the single 
surfactants systems. The plots of soluhiIit\ of PH]' against total surfactant 
concentrations in 16-s-16 nonionic and I -f-s- 14 nonionic surfactant systems are 
presented in Figs. 4.5 to 4.7. It observed that the .tfSR and K,,, values (Table 4.4) of 
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PI-IT in mixed surfactant is higher than those in single surfactant solutions except 
F108 in some cases. This may be due the large effective solubilization area in the 
mixed micelles than that of single Surfactant systems as a result of an increase in 
the radius of the mixed micelles including the electric dipole [35]. 
Treiner and coworkers [36-38j have suggested that the partition 
coefficient of natural organic solute between micelle and aqueous phase in mixed 
surfactants may he represented by the relationship 
in K,,,12 = X1n, InK„r! + ( 1— X1„.)In  K„,_ + BX ;
,7,  (1—X,") 	 (4.6) 
where K,, I _ . K,,,!  and K,,,2 are the micelle-water partition coefficients of the solute 
in mixed and single surfactant systems. respectively, and X,°' (X,J") represents the 
micelle mole fraction of surfactant l (2 ). As per Z_hou and Zhu 1391. B is all 
empirical parameter that incorporates both the surttictant-surfactant (as in f ”  ) and 
surfactant solute interactions. When B = 0. mixing has no effect on the 
partitioning of solute. but B > 0 or B °' 0 implies that K,,, in the mixed surfactant 
system is larger than that predicted by ideal mixing, rule. 
Table 4.4 lists the values of B e% aluated for the studied equimolar binary 
surfactant s, stems. The values of B are found to he positive for the all surfactant 
mixtures. Here. there is no distinct relationship between the values of B and /f”. 
because the value of B must depend both on surfactant-surfactant and surfactant-
solute interactions in the mixed micelles. Further understanding of the mixing 
eftect of the gemini.-nonionic surfactants on solubilization of P11'! is made on the 
201 
basis of the deviation ratio (R) between the e\perinlental molar solubilization 
(aISR,.n,) and the ideal value ( ,LLSR,,r•~,rl- C\ abated by R = NSR,s,,lMSR,d,,,r, where 
itISR„ieai = ,MSR,a,. (.t1SR, is the experimental .tISR \ aloe of the solubilizate in the 
pure ith surfactant solution whose bulk mole fraction in the mixture is a,). The R > 
I values (l able 4.4) imply positive mixing effect of' surfactants on solubilization. 
All binan systems have R values greater than unity. In case of cationic-nonionic 
surfactant systems, a slight positive charge d`\ eloped on the mixed micellar 
surface facilitates micelle-water interface adsorption in addition to micellar core 
solubilization. resulting in the value of R greater than unity. 
Since B and R values are direct outcome of the individual K,„ and .WSR 
values respectively, correlation between the former two parameters is expected 
which is evident from Table 4.4. In spite of the disagreement between the values 
of R and B. both indicate positive de\ iation from ideality and reveal that the 
synergistic surfactant mixing. as indicated h\ the negative /!” value (Table 4.1) 
enhanced the solubilization of Pill. 
Therniodv namics of Solubilization 
From the thermodynamic point of \ ie . solubilization can he considered as 
normal partitioning of the PH F between two phases. micelle and aqueous. and the 
standard free energy of solubilization. \G.. can be represented by the 
expression [40] 
= —RT In K„ 	 (4.7) 
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Ilere R is the gas constant and T the absolute temperature. The ,A(;; values thus 
calculated are presented in 'Fable 4.4. For all the systems. the AG.° values come 
out to be negative indicating spontaneous soltrhilization. Among the pure surfactants 
the absolute . G value is the highest for F108. \\ hereas in mixed systems the AG; 
values are found to be higher than the pure. suggesting more solubilization of 
pill. 
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Table 4.1: Critical micelle concentration (cmc), ideal cmc (cmc*), micellar composition (X;m), interaction parameter (f m), 
activiA,  coefficients ("), surface excess (fd and minimum area per head group (Am;,) of equimolar binary surfactant 
mixtures ofgemini +nonionic surfactants at 30°C. 
Sur`actanl 	cmc 	I', x .166 A,,,, Mixed 	cmc 	cmc I', 	.106 Am,„ 	XjlXJ" 	 f,"Y/ 
system 	(mM) 	(mol m'•) (A2) surfactant 	(mM) 	(mM) (mol m'2) (A2) 
system 
16-4-16 0.028 1.62 
16.5.16 0.032 1.41 
16.6-16 0.038 1.24 
14414 0.141 1.52 
14-5-14 0.161 1.48 
14-6-14 0.192 1.44 
F108 0.034 0.75 
TSO 0.028 3.18 
T40 0.013 2.51 
102.73 16-4-16T40 0.013 0.028 0.55 299.56 3.21 0.50/0.49 0.4510.46 
118.19 16.4.16T86 0.011 0.018 0.65 257.10 .2.07 0.6010.40 0.7210.47 
134.50 16416'F108 0.021 0.031 0.52 316.49 .1.56 0.47/0.52 0.60!0.70 
108.93 16-5-16/140 0.015 0.030 0.59 278.49 •2.88 0.6210.48 0.5210.46 
112.15 16-5-1611'80 0.019 0.019 0.58 284.75 -1.59 0.6210.37 0.80/0.54 
115.31 16-5-16!F108 0.032 0.021 0.52 317.79 -1.77 0.49/0.50 0.63/0.65 
220.58 16.6.16/140 0.014 0.032 0.61 271.09 -2.65 0.54/0.46 0.5710.46 
55.26 16.6.161780 0.011 0.019 0.58 282.74 -2.65 0.62/0.38 0.6810.36 
66.32 16-6-16/F108 0.017 0.036 0.52 316.85 -3.78 0.5110.49 0.4010.37 
14.4-14(140 0.034 0.047 0.67 248,19 -1.84 0.7110.28 0.86/0.39 
14-4.14.780 0.020 0.024 0.71 234.74 -1.58 0.81/0.18 0.95'0.35 
14.4-14!F810 0.051 0.05 I 0.58 286.57 .0.53 0.7610.23 0.9710.73 
14-5-14/1400.035 0.048 0.68 242.29 -1.93 0.7310.26 0.86'0.36 
	14.5-141T80 0.022 0.024 	0.67 	246.31 -0.97 0.86/0.14 0.9810.48 
14-5-14/F108 0.051 0.056 	0.58 	283.76 -0.65 0.75/0.24 0.970.67 
14-6-141T40 0.037 0.049 	0.67 	247.19 -1.85 0.7910.21 0.8810.36 
14.6-14/180 0.021 0.024 	0.62 	266.31 -1.63 0.84/0.16 0.9610.34 
14.6-14/F108 0.052 0.059 	0.52 	283.76 -0.73 0.7910.21 0.9710.63 
Table 4.2: The surface composition (X), interaction parameter (fi°) and activity 
coefficients (f,~) of binary surfactant mixtures ofgemini + nonionic surfactants at 
30 °C. 
System 	X,° 	f ° 	f C 	 ,fza 
16-4-16!T 40 0.56 -3.29 0.53 0.35 
16-4-16/T80 0.60 -3.81 0.55 0.25 
16-4-16/F108 0.59 -1.57 0.77 0.58 
16-5-16/T40 0.58 -4.31 0.47 0.23 
16-5-16/T80 0.65 -3.20 0.67 0.26 
16-5-16/F108 0.66 -1.04 0.88 0.64 
16-6-16/T40 0.58 -4.61 0.44 0.21 
16-616/T80 0.64 -3.76 0.61 0.21 
16-6-16/F108 0.59 -3.59 0.55 0.29 
14-4-14/T40 0.68 -4.66 0.62 0.12 
14-4-14/T80 0.74 -4.12 0.76 0.10 
14-4-14/F 108 0.76 -2.34 0.87 0.26 
14-5-14/140 0.70 -3.46 0.73 0.18 
14-5-141T80 0.70 -5.30 0.61 0.08 
14-5-14/F108 0.69 -3.80 0.69 0.17 
14-6-14/7F40 0.66 -4.54 0.59 0.14 
14-6-14/T80 0.69 -5.26 0.60 0.08 
14-6-14/F 108 0.74 -2.16 0.86 0.31 
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Table 4.3: Various thermodynamic parameters (AG X ,  AGm ,  Gmin and AG,JJ ) for 
16-s-16 /14-s-14 + nonionic mixed surfactant systems at 30 °C. 
Mole fraction AGO 
(kJ mol"') 
AGO 
(kJ mol"') 
G,„,,, 
(kJ mol"') 
LG ,,. 
(kJ rnol"5 
16-4-161T40 
0 -36.5 25.9 -54.0 
0.5 -2.0 -38.5 55.3 -88.7 
1 -36.6 15.2 -50.3 
16-4-16/T80 
0.5 -1.2 -38.8 61.2 -92.1 
1 -38.4 12.3 -48.2 
16-4-16/F108 
0.5 -1.0 -37.2 74.2 -96.9 
1 -36.0 51.1 -79.0 
16-5-16/T40 
0 -36.2 29.7 -56.1 
0.5 -1.8 -38.1 55.3 -88.7 
1 -36.6 15.2 -50.3 
16-5-16/T80 
0.5 -0.9 -38.5 
1 
55.3 -82.3 
-38.4 12.3 -48.2 
16-5-16/Fl 08 
0.5 -1.1 -37.2 69.1 -88.7 
1 -36.0 51.1 -79.0 
16-6-16/T40 
0 -37.6 33.5 -51.3 
0.5 -1.7 -38.3 57.4 -85.9 
1 -36.6 15.2 -50.3 
16-6-16/T80 
0.5 -1.6 -38.9 57.7 -89.5 
1 -38.4 12.3 -48.2 
16-6-16/F 108 
0.5 -2.6 -37.8 64.8 -96.1 
1 -36.0 51.1 -79.0 
Contd... 
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14-4-14/T40 
0 -32.4 27.2 -51.1 
0.5 -3.0 -35.0 53.7 -98.0 
1 -36.6 15.2 -50.3 
14-4-14/T80 
0.5 -2.3 -37.4 57.1 -102.8 
1 -38.4 12.3 -48.2 
14-4-14[F108 
0.5 -2.7 -35.0 68.9 -99.7 
1 -36.0 51.1 -79.0 
14-5-14/T40 
0 -32.1 25.8 -55.6 
0.5 -2.9 -35.9 60.5 -96.4 
1 -36.6 15.2 -50.3 
14-5-14/T80 
0.5 -3.5 -37.1 59.2 -101.4 
1 -38.4 12.3 -48.2 
14-5-14/F108 
0.5 -2.6 -35.0 70.9 -101.9 
1 -36.0 51.1 -79.0 
14-6-14/T40 
0 -31.7 25.9 -56.2 
0.5 -2.8 -35.8 64.9 -100.8 
1 -36.6 15.2 - 50.3 
14-6-14/T80 
0.5 -3.3 -37.2 51.3 -94.3 
1 -38.4 12.3 -48.2 
14-6-14/F108 
0.5 -2.5 -31.9 66.7 -107.4 
1 -36.0 51.1 -79.0 
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Table 4.4: Molar solubilization ratio (MSR), In K,,,, free energy of solubilization 
(OG ), deviation ratio (R), and experimental interaction parameter (B) for single 
and binary surfactant systems at 30 °C. 
System AISRexF,1MSR,deQ! In K, R B AGS' s 
(kJmol'') 
T40 0.0786 11.35 -28.5 
T80 0.0821 11.39 -28.6 
F 108 0.1095 11.65 -29.3 
16-4-16 0.0754 11.31 -28.4 
16-5-16 0.0756 11.46 -28.8 
16-6-16 0.0761 11.47 -28.8 
14-4-14 0.0625 11.26 -28.3 
14-5-14 0.074 11.44 -28.7 
14-6-14 0.0748 11.45 -28.7 
16-4-161F40 0.1014/0.077 11.58 1.32 1.02 -29.1 
16-4- 161T80 0.1066/0.079 11.63 1.36 1.20 -29.2 
16-4-16/F108 0.1199/0.092 11.73 1.29 0.96 -29.4 
16-5-16/T40 0.0851/0.077 I1.59 I.10 0.43 -29.1 
16-5-16sT'80 0.0974/0.079 11.73 1.24 1.03 -29.5 
16-5-16/F 108 0.148410.093 12.20 1.60 2.14 -30.6 
16-6-167140 0.1510/0.077 12.22 1.95 2.97 -30.7 
16-6-167180 0.1301/0.072 12.05 1.64 2.35 -30.3 
16-6-16/F 108 0.1491/0.093 12.21 1.61 2.18 -30.6 
14-4-14/140 0.0928/0.071 11.68 1.32 1.74 -29.3 
14-4-147180 0.0933/0.072 11.69 1.29 2.47 -29.3 
14-4-14/F108 0.1139/0.086 11.91 1.32 2.82 -29.9 
14-5-147140 0.1008/0.076 11.77 1.32 1.58 -29.6 
14-5-141180 0.1150/0.078 11.92 1.47 3.89 -29.9 
14-5-14/F 108 0.1368/0.092 12.11 1.49 3.30 -30.4 
14-6-14/140 0.1013/0.077 11.78 1.32 1.65 -29.6 
14-6-147180 0.1192/0.078 11.96 1.52 3.65 -30.0 
14-6-14/F 108 0.1462/0.092 12.18 1.59 3.92 -30.6 
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